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ABSTRACT OF THE DISSERTATION 
THE EFFECT OF STIGMA ON TREATMENT ADHERENCE AMONG HIV 
POSITIVE ALCOHOL USERS IN HAITI 
by  
Muni Balakrishnan Rubens 
Florida International University, 2016 
Miami, Florida 
Professor Jessy G. Dévieux, Major Professor 
Haiti reports the second highest prevalence of HIV among the Caribbean nations. 
People living with HIV/AIDS (PLWH) report stigmatic experiences, inadequate social 
support, depression, and anxiety, thereby affecting treatment adherence. This study 
examined the relationship between HIV-related stigma and treatment adherence, 
considering the effects of depression, anxiety, social support, and coping.   
The current study is a secondary analysis of baseline data collected from 362 
PLWH from Haiti. The measures included: Community Programs for Clinical Research 
on AIDS (CPCRA) adherence questionnaire; Perceived Stigma scale; Brief COPE 
questionnaire; State-Trait Anxiety Inventory (STAI); Centers for Epidemiological Studies 
Depression Scale (CES-D); and modified Medical Outcome Study Social Support Survey 
(mMOS-SSS). Descriptive statistics were used for demographic characteristics. T tests, 
Person correlations, multivariable linear regressions and structural equation modeling 
(SEM) were used for estimating the strength of associations and mediating effects.  
Mean age of the sample was 35.72±8.50 years and 37.0% were men. The mean 
self-reported treatment adherence was 93.1 percent. About 50.2% reported high levels of 
vii 
 
perceived stigma, 58.1% reported high levels of social support, 51.1% reported high 
levels of coping, 45.6% reported depression and 47.2% reported anxiety.  Multivariable 
regression showed that treatment adherence was directly associated with quality of care 
satisfaction scores (Beta = .032, p = .041) and inversely associated with perceived stigma 
(Beta = -0.049, p = .031). Depression was directly associated with perceived stigma-
public view (Beta = 1.877, p = .037) and inversely associated with tangible/informational 
social support (Beta = 1.877, p = .020). SEM analyses showed significant associations 
between perceived sigma and coping (Beta = .175, p = .003), perceived sigma and 
anxiety (Beta = .164, p = .005), coping and anxiety (Beta = .229, p <.001), and anxiety 
and treatment adherence (Beta = -.140, p = .018). Maladaptive coping mediated the 
relationship between stigma and anxiety levels which in turn adversely affected treatment 
adherence.    
In summary, HIV-related stigma was associated with lower levels of treatment 
adherence, and higher levels of depression and anxiety. These findings could be 
informative for future large scale studies on stigma, coping, anxiety and depression and 
planning effective interventions for improving treatment adherence. 
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CHAPTER I: Introduction and Specific Aims 
HIV and Stigma 
From the very onset of the pandemic, HIV/AIDS has been associated with 
increased stigma (Parker & Aggleton, 2003; Scambler, 2003). HIV/AIDS has been 
associated with stigmatized groups such as men who have sex with men (MSMs), 
commercial sex workers and injection drug users (IDUs; Parker & Aggleton, 2003). In 
spite of evidence of higher HIV transmission rates through heterosexual contacts 
globally, MSMs and IDUs have been implicated for acquiring and transmitting the 
disease (Lekas, Siegel, & Leider, 2011; Liamputtong, 2013). Even among heterosexuals, 
HIV/AIDS has been stereotypically associated with commercial sex work, and women 
bear the brunt of stigmatization and discrimination. These discriminatory acts have in 
many instances violated human rights and extended to extreme forms of physical and 
mental abuse (Deacon et al., 2005).  As Mann and Tarantola (1998) have suggested, 
“those who – before the arrival of HIV/AIDS – were socially marginalized, stigmatized 
or discriminated against, were found gradually and increasingly to bear the brunt of the 
HIV/AIDS epidemic. Human rights violations are now recognized to be primordial root 
causes of vulnerability to the epidemic” (Mann & Tarantola, 1998, p. 8). 
It has been repeatedly stated that HIV/AIDS because of its very nature of 
transmission initiates a high level of stigmatization and discrimination (Brimlow, Cook, 
& Seaton, 2003; Lekas et al., 2011; Parker & Aggleton, 2003). Thomas (2006) has 
described this process as a devaluation based on stereotyping and prejudice, where 
individuals tend to degrade those affected as “discreditable or unworthy, resulting in the 
person experiencing stigma becoming discounted or tainted” (Thomas, 2006, p. 3175). 
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Stigma also includes the individual’s fear and perceived threat about being discovered 
about the stigmatizing condition by the family or the community (Sivaram et al., 2009). 
Parker and Birdsall (2005) have explained this arm of stigma as prejudiced identity that 
sets apart affected individuals or groups because of their self-perceived and heightened 
negative perceptions and values towards their disease or condition (W. Parker & Birdsall, 
2005).  
Deng and colleagues (2007) have also identified stigma as a social construct 
resulting from cultural, historical, social, and situational factors subjecting the affected 
individuals to feelings of shame or guilt. One of the major products of stigmatization is 
discrimination where a stigmatized individual is judged unfairly or unjustly due to the 
perception that the individual is at fault for his/her condition (Deng, Li, Sringernyuang, & 
Zhang, 2007). HIV/AIDS has also been misconstrued as a disease that affects the 
individuals who have breached the moral and ethical standards of divine justice and 
threatened the very ethical and moral standards of the society (Zhou, 2007). Stigma may 
be expressed as verbal abuse, gossip, isolation, humiliation, rejection or neglect of 
individuals (Deng et al., 2007; Thomas, 2006). These manifestations may increase over 
time and become consolidated by ignorance, inaccurate information, and misconstrued 
perceptions about the disease by the infected population as well as the public 
(Apinundecha, Laohasiriwong, Cameron, & Lim, 2007; Sweat & Levin, 1995; Zhou, 
2007). 
Background 
Since the first case of AIDS was identified in 1981 and human immunodeficiency 
virus (HIV) was identified as the causative agent, this disease has become a leading cause 
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of mortality and morbidity worldwide (Centers for Disease Control and Prevention 
[CDC], 1981; Gallo et al., 1984). In the year 2013, global estimation showed that 
approximately 35 million people were living with HIV infection (World Health 
Organization [WHO], 2015a). Since the initial identification and characterization of the 
disease, about 78 million people have become infected and 39 million people have died 
from AIDS and related conditions (Joint United Nations Programme on HIV/AIDS 
[UNAIDS], 2014a). About 2.1 million people have become newly infected with HIV in 
the year 2013 (UNAIDS, 2014b).    
Since the advent of antiretroviral medications, HIV infection has become a 
chronic disease with decreasing incidence and increasing prevalence. There were 29.8 
million people living with HIV in 2001, and in 2014 the number has increased to 36.9 
million. However, the global prevalence rate (percentage of people 15-49 years old who 
are infected) has leveled since 2001 and was 0.8% in 2014 (UNAIDS, 2015c). In the year 
2013, about 12.9 million people were receiving some form of antiretroviral medication 
and constituted only 37% of all infected cases globally (UNAIDS, 2014d). According to 
the global estimates, about $19.1 billion were spent on HIV/AIDS and related conditions 
in the year 2013 (Kaiser Family Foundation, 2014). This is a great burden on both 
developed as well as developing economies because more than 50% of these total 
expenses are directed towards underdeveloped nations with decreased productive 
capacity and increased HIV associated life loss years. Haiti is one such Caribbean nation 
with the second highest prevalence of HIV among Latin America and the Caribbean and 
also the highest number of people living with HIV (PLWH) in this geographical area. 
UNAIDS estimated that about 150,000 people are living with HIV in Haiti and 
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prevalence among adults between 15-49 years is 2.2 percent (UNAIDS, 2013e). Haiti 
also reported 7,500 AIDS related deaths in 2012 (WHO, 2012b). The epidemiological 
severity of HIV/AIDS in Haiti is further complicated by many factors such as limited 
availability of antiretroviral therapy (ART), non-compliance to ART, substance abuse 
and stigma associated with the disease (Boulle & Ford, 2007; Castro & Farmer, 2005; 
Young, Wheeler, McCoy & Weiser, 2014).  
Stigma and Discrimination 
Individuals coping with chronic illnesses have always been perceived as weak, 
dependent, or a burden on society. Many illnesses are associated with irresponsible or 
poor lifestyle choices (Millen & Walker, 2000). HIV/AIDS is one such disease and 
research has consistently found that HIV/AIDS is far more stigmatizing than other 
chronic illnesses such as cancer, diabetes, heart disease or infectious diseases like 
tuberculosis and leprosy because of its association with homosexuality (Liamputtong, 
2013).     
The word stigma is derived from ancient Greek, meaning “mark” (Jones, 1987). 
Stigma has always produced negative impacts on the life, health and well-being of the 
individuals subjected to it (Liamputtong, Fanany, & Verrinder, 2012). Stigma has its 
basis in “differences” in age, gender, race, socioeconomic status, disability, appearance, 
personality, illness, color, sexuality and specific behaviors which evoke panic, 
abhorrence, discontent or pity from individuals belonging to the same or other population 
groups (Whitehead, Carlisle, Watkins, & Mason, 2001). The main element of 
stigmatization strategies includes social schism to create a “them and us” divide and lay a 
foundation for classification of individuals as “good and in favor” or “bad and out of 
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favor” within a given socio-political setting (Foucault, 1973; Whitehead et al., 2001, p. 
89).  
Stigma also shows the phenomenon of self-perpetuation once the initiation of this 
socio-political schism occurs. The factors that aid in perpetuating stigma include 
prejudice, religious beliefs, social norms, superstition, ignorance, lack of knowledge and 
transmission of beliefs and thoughts across succeeding generations (Deacon, Stephney, & 
Prosalendis, 2005). Sontag (1991) suggested that HIV/AIDS has been associated with the 
“sinful” and “evil,” and PLWH are branded as “immoral” and “depraved” (Sontag, 1991, 
p. 90). As a consequence, they are socially unrecognized and considered as “not one of 
us” leading to discrimination (Whitehead et al., 2001, p. 126).  
Multidimensional Aspects of HIV-Related Stigma 
Though there are many arms of HIV-related stigma, they have been broadly 
classified into three subtypes (Bond, Chase, & Aggleton, 2002; Thomas, 2006; 
Vanlandingham, Im-Em, & Saengtienchai, 2005). ‘Internalized stigma’ occurs due to 
self-blame and self-deprecation by the individuals themselves because of their perceived 
beliefs and knowledge about the acquisition of the disease. ‘Anticipated stigma’ relates to 
the fear of being discriminated by willful or accidental disclosure of the disease condition 
resulting in constant avoidance or concealment of the disease, as well as the anxiety 
associated with the accidental disclosure of the disease. ‘Enacted stigma’ occurs because 
the individuals have experienced tangible discriminatory acts from non-infected 
individuals which could be actual or perceived. However, Parker and Aggleton (2003) 
have suggested that stigma may manifest in varied forms specific to the sociocultural 
context of the individuals, and the accompanying discrimination also varies across 
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cultural diversities and complexities (Parker & Aggleton, 2003). Zhou (2007) 
recommends that sociocultural beliefs, moral beliefs and values within local contexts 
should always be considered to better understand the factors affecting stigma and 
discrimination in a given community. Stigma also changes temporally and therefore the 
currently accepted dimensions related to stigma will not absolutely represent the 
established dimensions in the past or the evolving dimensions in the future. Thus stigma 
and discrimination constitute a continuously evolving phenomenon (Zhou, 2007).  
HIV Stigma and Treatment Adherence 
ART has been the most critical determinant of control over HIV viral RNA and 
HIV/AIDS related conditions (Bangsberg et al., 2000; Bangsberg et al., 2001; Paterson et 
al., 2000). Many studies have positively associated ART adherence and cognitive 
processes such as knowledge, perception and health literacy (Maggiolo et al., 2002; 
Mehta, Moore, & Graham, 1997). Recent studies have also associated lack of ART 
adherence with structural barriers such as geographic isolation, lack of transportation, 
food insecurity and lack of money and resources for treatment alternatives (Hardon et al., 
2007; Kalofonos, 2010; Nagata et al., 2012; Pyne-Mercier et al., 2011; Taiwo et al., 
2010; Weiser et al., 2010).    
HIV/AIDS related stigma is another barrier that adversely affects many aspects of 
HIV-related care including HIV testing, HIV serostatus disclosure and ART adherence 
(Cree, Kay, Tisdall, & Wallace, 2004). The process of enacted stigma and perceived 
stigma prevent the patient from seeking active medical services and force them towards 
concealing their seropositive status or refusing to be tested and treated (Bond et al., 2002; 
Thomas, 2006). Despite substantial evidence of stigma acting as a barrier in effective 
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management of HIV in several populations worldwide, the mechanisms through which 
stigma compromises ART adherence in Haitian HIV positive alcohol users needs further 
explorations. This is an important gap in the literature which needs to be filled in order to 
improve treatment outcomes and the quality of life in these HIV positive patients.  
HIV-Related Stigma and Depression 
HIV-related stigma produces feelings of shame, guilt and concern regarding the 
disclosure, which in turn results in negatively perceived self-image. Such negative 
attitudes and perceptions can exacerbate mood disorders such as major depressive 
disorder, anxiety and panic attacks, and obsessive compulsive disorders (Chandra, 
Deepthivarma, Jairam, & Thomas, 2003; Whetten, Reif, Whetten, & Murphy-McMillan, 
2008). HIV also produces feelings of self-loathing, guilt and shame among people 
diagnosed with the condition (Emlet, 2007). In extreme forms, these feelings could be 
transformed into intense depression and despair; PLWH often report extreme social 
withdrawal and acceptance of impending death (Hong, Anh, & Ogden, 2004). When 
compared to the general population, PLWH report 2-3 times increased rates of depressive 
disorders (Mogga et al., 2006). This could be especially true in underdeveloped countries 
such as Haiti where the prevalence of depressive disorders is as high as 41.7% in the 
general population (Surkan et al., 2010; Wagenaar, Hagaman, Kaiser, McLean, & Kohrt, 
2012; Dévieux et al., 2013). Depressive disorders have been associated with many 
adverse health-related outcomes such as poor adherence to medications, faster 
progression to AIDS and poor quality of life in HIV positive patients (Ammassari et al., 
2004; Bouhnik et al., 2005; Treisman & Angelino, 2007; Malow et al., 2013). 
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HIV-related stigma, gender, lower education, unemployment, compromised 
immune status, and increased rate of opportunistic infections are some of the variables 
associated with depression in HIV positive patients (Burack et al., 1993; Leserman et al., 
2000; Olley, Seedat, Nei, & Stein, 2004; Sherbourne et al., 2014; Simbayi et al., 2007). 
Additionally, HIV-related stigma adversely affects health service utilization and 
psychological well-being (Bond et al., 2002; Chesney & Smith, 1999; Lichtenstein, 
Laska, & Clair, 2002). In spite of profound effects on general well-being and quality of 
life, HIV-related stigma has often been overlooked in many scientific studies 
(MacQuarrie, Eckhaus, & Nyblade, 2009). Similarly, major depressive disorders have 
also been associated with compromised immunological and virological variables such as 
lower CD4 counts and uncontrolled viral load (Olley et al., 2004). Major depressive 
disorders have been associated with female gender, younger age and unemployment 
status (Akena, Musisi, & Kinyanda, 2010; Nakimuli-Mpungu, Musisi, Mpungu, & 
Katabira, 2006). Many of these factors may have a bearing on treatment outcomes in 
PLWH.  
Current Study 
Using secondary data from the parent study titled “Intervening with Haitian HIV 
positive Alcohol Users: An Environmental Psychosocial Framework,” the current 
dissertation examined the effect of stigma on HIV treatment adherence. This study 
examined the effects of HIV-related stigma on coping strategies affecting medication 
adherence and anxiety. In addition, this study also examined the relationship between 
depression and HIV-related stigma. The parent study was an adapted randomized 
controlled trial of a Cognitive-Behavioral Stress Management (CBSM-A) intervention for 
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simultaneously enhancing safer sex practices, adherence to ART medication, and 
reducing alcohol or other drugs use, in a predominantly poor urban population in Haiti. 
The parent study included 389 alcohol using, HIV positive individuals. The experimental 
group was administered the CBSM-A, an adapted intervention guided by the 
Information-Motivation-Behavioral Skills (IMB) theory. The intervention used a small-
group design for HIV positive alcohol-using populations, which also addressed their 
cognitive/self-management and coping barriers that could impede sustainable outcomes, 
particularly in resource-constrained settings such as Haiti. In the parent study, the CBSM-
A intervention was compared with a wait-list control group where participants received 
the intervention following their 6-month follow-up assessment. 
The following aims and hypothesis were tested in this study: 
Aim 1: To understand the relationship between HIV-related stigma and HIV treatment 
adherence in a sample of HIV positive alcohol users in Haiti. 
Research Question 1: Does HIV-related stigma significantly affect HIV treatment 
adherence in a sample of PLWH in Haiti? 
Hypothesis 1: Among PLWH, levels of HIV-related stigma will be significantly 
associated with levels of HIV treatment adherence.  
 
Aim 2: To understand whether coping strategies act as a mediator between HIV-related 
stigma and HIV treatment adherence. 
Research Question 2: Do coping strategies used to deal with HIV-related symptoms 
mediate the relationship between HIV-related stigma and HIV treatment adherence? 
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Hypothesis 2: Among PLWH, coping strategies act as a mediator between HIV-related 
stigma and HIV treatment adherence. 
 
Aim 3: To understand whether coping strategies act as a mediator between anxiety and 
HIV treatment adherence 
Research Question 3: Do coping strategies used to deal with HIV-related symptoms 
mediate the relationship between anxiety and HIV treatment adherence? 
Hypothesis 3: Among PLWH, coping strategies act as mediator between anxiety and 
HIV treatment adherence. 
 
Aim 4: To understand the relationship between HIV-related stigma and depression  
Research Question 4: Does HIV-related stigma significantly affect depression in 
PLWH? 
Hypothesis 4: Among PLWH, HIV-related stigma will be significantly associated with 
higher levels of depression.  
 
Aim 5: To understand whether social support acts as a mediator between HIV related 
stigma and depression symptoms  
Research Question 5: Does social support mediate the relationship between HIV related 
stigma and depression?  
Hypothesis 5: Among PLWH, social support will act as a mediator between HIV related 
stigma and depression.   
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Theoretical framework 
Stress and coping theories provide frameworks to relate how individuals cope and 
react to psychologically stressful situations (Matthieu & Ivanoff, 2006). Stigma 
represents a stressful psychological situation in which an individual internalizes negative 
beliefs, opinions and feelings towards himself/herself (Logie, Newman, Chakrapani, & 
Shunmugam, 2012). Evidence indicates that PLWH often accept the stigma associated 
with their disease; this acceptance adversely influences their physical and mental health 
(Kalichman et al., 2009). Kalichman and colleagues (2009) reported that the stigma 
associated with HIV/AIDS could act as significant barriers towards prevention, testing 
and care. The study also showed that internalized HIV-related stigma was consistent 
across PLWH from geographically diverse locations such as South Africa, Swaziland and 
Atlanta, GA, U.S. This study also reported that the social stigma of HIV/AIDS follows 
the classic model of stigma identified by Goffman’s seminal 1963 study. Goffman 
defined three dimensions of stigma relating to flaws in personal character and include: 
disgraced social identity; physical abnormalities or defects; and racial stigma (Goffman, 
1963). Green (1995) in a street survey among 300 non-infected participants and 42 
PLWH in Glasgow and Edinburgh documented these attributes in the general public 
(Green, 1995). 
Stress theory dates back to Hans Selye’s benchmark research and his book on the 
“Stress of Life” (Selye, 1956). A psychosocial stressor refers to the reaction of an 
individual to a response or stimulus that he/she perceives as a threat (Matthieu & Ivanoff, 
2006). The concept of HIV stigma falls under the definition of a psychosocial stressor. 
HIV stigma creates stress from the prejudiced attitudes and discrimination toward 
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PLWH. Understanding the stress stimulus allows the ability to target interventions to deal 
with this response. 
Coping theory encompasses the concept of the adaptation response in an 
individual to a stressful situation. Coping involves self-directing endeavors targeted 
towards diminishing the harmful effects of stressors (Varni, Miller, McCuin, & Solomon, 
2012). Coping strategies may involve approach (engagement) or avoidance 
(disengagement) responses to stressors. PLWH using disengagement coping to deal with 
stressors show a higher association with depression, anxiety and emotional distress; 
whereas PLWH employing engagement coping strategies demonstrate lesser depression 
and higher levels of satisfaction with life (Heckman, 2003).  
HIV related stigma and coping mechanisms significantly affect many outcome 
variables such as HIV treatment adherence, HIV symptomatology and anxiety towards 
the disease condition. Furthermore, anxiety disorders among PLWH are eight times 
higher than in the general population (Varni et al., 2012). Anxiety and the symptoms of 
the disease are also negatively correlated with adherence to the medical regimen. In 
addition, another variable, social support, acts as a mediator for the relationship between 
depression and HIV related stigma (Rao et al., 2012). Because of the interrelationships 
between these variables, depression could also have significant adverse effects on HIV 
treatment adherence and anxiety. Figure 1 illustrates the all-encompassing model which 
was created to demonstrate this complex interrelationship.  
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Figure 1. Stress-coping model demonstrating interrelationship of variables. 
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CHAPTER II: Literature Review 
From the very onset of HIV/AIDS in the early 1980s, this pandemic has been 
considered both a medical and social illness (Herek & Capitanio, 1993; Letteney & 
Laporte, 2004). Scambler (2003) stated that HIV/AIDS has always been “both medicalized 
as disease and moralized as stigma” (Scambler, 2003, p. 199). Ever since its identification, 
HIV/AIDS has provoked powerful reactions from the public such as prejudices against 
“sex, drugs, death and contagion” (Scambler, 2003, p. 199). This uniqueness has made 
HIV/AIDS an extremely stigmatizing disease. This literature review explores the different 
associations and components of HIV-related stigma and its adverse effects. 
HIV Related Stigma 
 The conceptualization of stigma can be traced back to the work of Erving 
Goffman, who defined stigma as an "attribute that is deeply discrediting, reduces the 
stigmatized individual from a whole and usual person to a tainted, discounted one" 
(Goffman, 1963, p. 3). Building on this foundation, many researchers have successively 
discredited stigma as a social injustice that involves discriminatory behaviors and indirect 
harm to the stigmatized individual (Major & O'Brien, 2005). Link and Phelan (2001) 
developed an integrative approach for defining stigma in terms of four core components: 
distinguishing and labeling human differences; cultural beliefs perpetuating negative 
stereotypes; categorization of labeled persons in order to develop separation mentality 
(i.e. "us" versus "them"); and finally, status loss and discrimination experienced by 
labeled persons resulting in social injustice (p. 367). This definition also encompasses the 
broader forces acting in the stigmatization process, particularly social, economic, and 
political (Link & Phelan 2001, p. 367). Though personal responses to stigma significantly 
 24 
 
vary from individual to individual, self-stigma has been defined as the situation wherein 
individuals internalize and accept stigma-related devaluations and discriminations 
(Herek, 1990). The negative thoughts and feelings that result from these internalization 
processes lead to the creation of self-hatred and has been linked to increased depression, 
psychological distress, and decreased reliance on social support (Mak et al., 2007; Lee, 
Kochman, & Sikkema, 2002). 
 HIV-related stigma constitutes one of the significant barriers adversely affecting 
treatment adherence and thereby increasing transmissions rates of the disease (Katz et al., 
2013). HIV-related stigma has been identified as a social and structural phenomenon that 
involves stereotyping, status loss, and discrimination in many power structure settings 
existing in complex societies (Mahajan et al., 2008). Studies show that the most salient 
domains of HIV-stigma (that affect self-esteem and self-acceptance in PLWH) include 
blame, stereotypes, and fear of contagion (Sayles et al., 2007). Stigma is thus a complex 
social process (Earnshaw & Caudoir, 2009), with varied and profound implications, 
particularly for PLWH (Lee, Kochman, Sikkema, 2002). HIV-related stigma has been 
linked to the creation and maintenance of social inequalities, often along the lines of race, 
class, gender, and sexual orientation (Parker & Aggleton, 2003). This is additionally 
complicated by stigmas related to drug use, and homosexuality (Reidpath & Chan, 2005; 
Crawford, 1996). Moreover, several studies have shown that HIV-related stigma is more 
intense when compared to the stigmas associated with other illnesses such as herpes, 
cancer, tuberculosis etc. (Peters et al., 1994). HIV-related stigma has significant effects 
not only on the diagnosed individuals, but also their family members (Bogart et al., 
2008), their health workers and volunteers (Snyder et al., 1999).   
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Earnshaw and Chaudoir (2009) developed the HIV Stigma Framework to 
understand the specifics as well as the effects of stigma experienced by PLWH. The HIV 
Stigma Framework proposes three distinct stigma mechanisms: internalized, anticipated, 
and enacted HIV stigma categories (Earnshaw & Chaudoir, 2009). Many studies have 
utilized this framework to investigate stigmatic experiences among PLWH.   
Internalized Stigma: The PLWH tend to endorse the negative feelings and beliefs of 
others and internalize these feelings to themselves thus leading to internalized stigma. In 
a study on internalized stigma, Lee, Kochman, and Sikkema (2002) found that the 
majority of those having internalized stigma were diagnosed more recently; were 
receiving less support and acceptance from their families; knew fewer people with HIV; 
and were less likely to participate in HIV support groups. People experiencing higher 
levels of internalized stigma worry more about spreading their infection to others and 
report higher levels of hopelessness, anxiety and other depressive symptoms (Lee, 
Kochman, Sikkema, 2002). Among PLWH, internalized stigma generates feelings of 
shame and guilt and the affected individuals see themselves as dirty/unclean and 
deserving of the negative outcomes enforced upon them (Earnshaw et al., 2013).   
Anticipated Stigma: HIV stigma also manifests as anticipated stigma, wherein PLWH 
anticipate negative attitudes, treatment complications, and acts of discrimination because 
of their very HIV positive status (Earnshaw et al., 2013). Research shows that 
experiencing this type of stigma is associated with increased physical illness (Quinn & 
Chaudoir, 2009) and stress related symptoms (Pascoe & Richman, 2009).  
Enacted Stigma: The third category, enacted stigma, includes the actual experiences of 
stereotyping, discrimination, social exclusion, and other forms of prejudices enforced by 
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others on the person experiencing the stigmatic condition (Earnshaw, et al., 2013).  
Enacted stigma among PLWH has been associated with poor health outcomes, in terms of 
both physical and psychological well-being (Earnshaw et al., 2015; Logie & Gadalla, 
2009). Enacted stigma has been associated with worsening HIV progression such as 
lower CD4 counts, uncontrolled viral load, opportunistic infections and faster progression 
to AIDS (Earnshaw et al., 2013; Holzemer et al., 2007). Despite advances in treatment 
and management of HIV/AIDS and ongoing educational campaigns, the misconceptions 
held by the public regarding the contagion still persist, leading to greater instances of 
enacted stigma (Ware, Wyatt, & Tugenberg, 2006).   
HIV and Mental Health 
 It has long been recognized that PLWH face significant psychosocial challenges 
often resulting in complex mental health issues (Catalan, Burgess, & Klimes, 1995). 
Many researchers have also suggested that PLWH experience greater psychological 
distress when compared to the general population (Stutterheim et al., 2009). However, 
psychiatric illnesses among these patients have often being under reported (Gatz, 
Brownstein, & Taylor, 2005). Many studies on the health challenges faced by PLWH 
identify mental health problems as one of the most common comorbidities associated 
with HIV (Edmiston, Passmore, Smith, & Petoumenos, 2015; Kendall et al., 2014). After 
comparing clinico-psychological reports of PLWH over a period of 24 years, Adams and 
colleagues (2016) reported that though acute mental health syndromes and organic brain 
disorders have declined, depression and anxiety disorders (often chronic) have increased 
over the years. Additionally, new mental health problems related to recreational drug use 
and co-infections (e.g. HIV and Hepatitis C) are increasing among PLWH, justifying the 
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continued need for increased mental health services for this population (Adams et al., 
2016). Ironically, mental health research and treatment facilities for HIV positive patients 
are lacking, especially in resource limited settings such as Haiti (Dow et al., 2016; Klasen 
& Crombag, 2012; Castro & Farmer, 2005). The majority of PLWH are already 
vulnerable to mental health problems. PLWH living in resource limited settings have 
additionally elevated risks for anxiety disorders, PTSD, depression (Betancourt et al., 
2014; Seth et al., 2014; Malow et al., 2013) and suicidal ideations (Marzuk et al., 1997) 
compared to the general population. PLWH in mid- to later-life also face specific 
challenges such as emotional distress and suicidal thoughts and require targeted and long-
term interventions and psychiatric care (Kalichman et al., 2000; Heckman, 2000; 
Heckman, 2002).   
Stigma and Mental Health among PLWH   
HIV-related stigma represents a significant risk factor for mental health problems 
among PLWH (Earnshaw & Chaudoit, 2009). Research has consistently shown that 
higher levels of stigma are associated with lower levels of mental health in PLWH (Logie 
& Gadall, 2009). HIV-based discrimination and prejudice have serious impacts on 
psychological health (Steward et al., 2011), with stigma experiences being linked to 
depression, anxiety, and risky sexual behaviors (Vanable et al. 2006; Preston et al., 
2007). Some researchers have conceptualized that the psychological and emotional 
challenges such as illness, fear of death, poverty, and social isolation lead to “chronic 
sorrow” and stigma additionally aggravates these factors in PLWH (Lichtenstein, Laska, 
& Clair, 2002). They have also recommended that stigma should be considered as a 
potential marker for psychiatric problems, specifically chronic depression.  
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The effects of HIV-related stigma become additionally detrimental when multiple 
types of stigmas act in combination – for instance race- or sexual orientation-based 
stigma combined with fear of contagion stigma. Lelutiu-Weinberger and colleagues 
(2015) in their study on men who have sex with men (MSM) of color have highlighted 
the adverse effects of these types of combined stigmas. Their study showed that there are 
many adverse mental health outcomes associated with each individual type of stigma. 
The adverse outcomes associated with each specific stigma additively combine together 
when multiple stigmas are simultaneously acting on these individuals, thereby increasing 
their risks for mental, emotional, and psychological problems (Lelutiu-Weinberger et al., 
2015; Balsam et al., 2011; Stirratt et al., 2008). The negative mental health outcomes of 
compounded stigmas have been reported in many minority populations. For example, 
minority PLWH in the U.S. who experienced discrimination due to age (Emlet et al., 
2015; Emlet, 2006) or race (Singleton, et al. 2015) when compounded with other specific 
stigmas showed higher susceptibilities to mental health problems. 
Anxiety, Stigma & Treatment Adherence 
The burden of social and physical coping mechanisms used by the PLWH to 
manage their diseased states are worsened due to stigma and discrimination experienced 
by this population (Colbert et al., 2010). Though there are many mental health problems 
experienced by this population, depression and anxiety predominate (Sunderland et al., 
2010). Anxiety disorders among PLWH have been associated with stigma and 
discrimination and some studies have suggested that HIV-related stigma leads to social 
isolation, fear, and other negative emotional consequences exacerbating anxiety disorders 
(Fullilove, 1989). Stigma has been identified as a predisposing factor for many anxiety 
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disorders (Katz & Nevid, 2005). Affective disorders such as generalized anxiety disorder, 
panic disorder, major depressive disorder, post-traumatic stress disorder, and dysthymia 
are two to three times more common in PLWH experiencing higher levels of stigma 
(Safren et al., 2003; Adewuya et al., 2009). Among PLWH, the prevalence of anxiety 
disorders varies from 20% to as high as 47% (Els et al. 1999; Celesia et al., 2013; Vitiello 
et al., 2003; Olagunju et al., 2012). While anxiety disorders may pre-exist among those 
diagnosed with HIV, it is generally exacerbated during stressful phases such as HIV 
diagnosis and coping, implicated largely in fear of death as well as HIV-related stigma. 
Emotional dysregulation among PLWH also contributes to greater anxiety and distress 
(Brandt et al., 2013). Moreover, HIV-related anxiety adversely affects general health 
outcomes in PLWH and has been associated with decreased life satisfaction scores, faster 
disease progression, and lower treatment adherence (Turner et al., 2003; Tucker et al., 
2003; Tsao et al., 2004). Increased anxiety levels have been associated with sub-optimal 
treatment adherence in many studies (Panigrahi, Swain, & Mohanty, 2015; Pappin, 
Wouters, & Booysen, 2012; Celsia et al., 2010). Van Servellen and colleagues (2002) 
found that anxiety scores among HIV positive patients were significantly related to both 
self-reported non-adherence and clinically evaluated non-adherence. In another study, 
anxiety symptoms were associated with lower treatment adherence and compliance to 
ART schedules (Schönnesson et al., 2007). Even among PLWH without any diagnosed 
psychiatric illness, anxiety was found to be the most significant variable associated with 
sub-optimal treatment adherence (Schönnesson et al., 2007). This evidence strongly 
suggests that there is an adverse relationship between anxiety and HIV treatment 
adherence. Though there are many studies on the beneficial effects of reducing anxiety on 
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treatment adherence in other populations (Kemppainen et al., 2006), similar studies are 
lacking in Haitian PLWH. There is still a considerable gap in the literature regarding the 
effects of discrimination and anxiety disorders on HIV treatment adherence in 
marginalized populations such as Haitian PLWH.   
Depression and HIV   
Depressive disorders constitute the most common mental illness among PLWH 
(Choi, 2013) and have significant effects on interpersonal relationships, employment, 
quality of life, treatment adherence and survival (Kibret & Salilih, 2016). After being 
diagnosed with HIV, PLWH often struggle to adapt to the chronic disease condition, and 
suffer from depression and anxiety as they attempt to make sense of their current 
situation and come to terms with the social, mental, and physical challenges of the 
disease (Williams, et al., 2005; Green & Smith, 2004). A meta-analysis done by Ciesla & 
Roberts (2001) showed that the prevalence of major depressive disorders was nearly 
double among PLWH when compared to HIV-negative counterparts. Irrespective of these 
findings, studies continue to suggest that depression is under-diagnosed and under-
reported among PLWH (Rodkjaer, Laursen, Balle, & Sodemann, 2010). Depression has 
also been associated with impaired immunological responses and higher mortality rates 
(Sumari-de Boer, Sprangers, Prins & Nieuwkerk, 2012; Ironson et al., 2005). There is a 
definite need for understanding the prevalence of these disorders in PLWH. Bouhnik and 
colleagues (2005) suggested that depression on its own adversely affected clinical disease 
progression in PLWH, independent of the adverse effects of sub-optimal treatment 
adherence associated with depression. Cook et al. (2004) additionally found that AIDS-
related deaths were more likely among female PLWH with chronic depressive disorders 
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after controlling for many other factors. Studies have also reported that there is a direct 
relationship between severity of clinical depression and clinical disease progression in 
PLWH which strengthens over time (Lyketsos et al., 1996; Wells et al., 1989).    
HIV Treatment Adherence  
 Treatment adherence is a complex concept involving many domains: the patient; 
the disease; the medical care settings including treatment, relationship to caregivers, and 
the wider healthcare system; and the socio-cultural context (Ammassari et al., 2002). Due 
to its broad domains, it is very challenging to identify and target all the potential 
determinants of treatment adherence. Yet, it is crucial because many studies have 
recommended moderate to high levels of adherence to ART to achieve adequate control 
over the disease (Kobin & Sheth, 2011; Parienti et al., 2008; Shuter et al., 2007). HIV 
treatment typically involves a complex regimen of several pills consumed multiple times 
in a day. Some of the factors influencing HIV treatment adherence include: memory; 
adverse effects of medications; regimen complexity; domestic responsibilities; 
availability and access to medications; existing comorbidities; psychiatric problems such 
as depression and anxiety; and subjective knowledge and awareness about the disease 
(Gifford et al., 2000). Because of several factors involved, it would be beneficial to 
consider treatment adherence from a biosocial perspective. In biosocial approaches, 
analyses and interpretations are based on broader considerations of both the clinical and 
social factors affecting adherence and the dynamic interactions of these processes over 
time (Singer, 2003). Gaining insight into the particular socio-cultural contexts in which 
HIV treatment is occurring, and acknowledging the dynamic nature of such contexts 
would be useful in developing a more grounded understanding of the multiple and 
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evolving factors associated with adherence and non-adherence behaviors (Spire et al., 
2002; Ickovics & Meade, 2002). Treatment non-adherence among PLWH is thus a 
complicated and evolving issue of great importance. Non-adherence in HIV patients can 
lead to uncontrolled viral loads which in turn could increase the risk for sexual 
transmission as well as drug resistant viral strains (Lucas, 2005). Many studies have 
shown that effective and consistent adherence to ART decreases the risk of sexual 
transmission among sexual partners (Cohen et al., 2011).  
HIV Treatment Adherence and Mental Health  
As previously discussed, depression, anxiety and other mental health problems are 
highly prevalent among PLWH (Kilbourne et al., 2002) and have consistently been 
implicated for lower treatment adherence (Gonzalez et al., 2011; Turner et al., 2003). 
Non-adherence to HIV treatment is estimated to be three times greater among those with 
depression when compared to those without (DiMatteo, Lepper, & Croghan, 2000). Some 
of the factors associated with depression that may contribute to non-adherence include: 
sense of hopelessness; negative expectations; and pessimistic thoughts. Additionally, 
depressed individuals often have decreased social interactions, which, in the context of 
treatment adherence, may limit their access to some of the contacts necessary for 
maintaining compliance (both emotional and practical; Starace et al., 2002). In a 
longitudinal study, it was found that participants who reported depression during the 
baseline visit showed a two-fold decrease in treatment adherence during the follow-up 
after adjusting for covariates, thus underscoring the dynamic rather than static 
relationship between depression and treatment adherence (Kacanek et al., 2010). Yun and 
colleagues (2005) showed that HIV patients who adhered to antidepressant medications 
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also adhered to ART. However, this could have been due to higher adherence to all 
medications in general rather that the effects of anti-depressants on ART adherence. 
Similarly, in a large scale clinical study consisting of 3,359 PLWHs reporting depression, 
Horberg and associates (2008) found that greater adherence to selective serotonin 
reuptake inhibitor (SSRI) class of antidepressants was associated with improved HIV 
treatment adherence in terms of controlled viral load and recuperating CD4 T-cell counts. 
Many other studies have also reported improved HIV treatment adherence in PLWH 
receiving psychotherapeutic treatment (cognitive-behavioral therapy) for their depression 
(Safren et al., 2009; Weber et al., 2004; Kelly et al., 1993). A recent meta-analysis 
suggested that targeted and effective treatments for depression would not only positively 
impact adherence, but could also considerably improve quality of life and health 
outcomes in PLWH (Sin & DiMatteo, 2014).  
HIV Treatment Adherence and Stigma   
Stigma has shown to have pervasive negative effects on multiple aspects of HIV-
related care such as willingness and decision to be tested (Chesney & Smith, 1999), HIV 
status disclosure (Smith, Rossetto, & Peterson, 2008; Steward et al., 2008), and seeking 
social and psychological support (Logie & Gadalla, 2009; Mak et al., 2007). As outlined 
earlier, internalized stigma is often associated with maladaptive responses to social, 
mental and physical factors related to treatment adherence. In a review that examined 
both qualitative and quantitative variables related to stigma and HIV treatment adherence, 
it was found that HIV-related stigma adversely affected treatment adherence through 
many general and group-specific psychological processes. This review also reported that 
adaptive coping and social supports were crucial in determining the success achieved by 
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participants in overcoming structural and economic barriers towards effective treatment 
adherence (Katz et al., 2013). In a cross sectional study of PLWH in Hong Kong, 
researchers also found that higher rates of self-perceived stigma were reported by those 
who intentionally did not adhere to treatment regimen when compared to those who 
adhered to treatment or those who unintentionally failed to adhere (Mo & Mak, 2009). 
Experiences of stigma and discrimination have also been associated with increased odds 
of non-adherence in many other studies (Boyer et al., 2011; Li et al., 2010). In summary, 
the stress, social isolation, and diminished view of self, emanating from stigma lead to 
maladaptive repercussions against treatment regimens and achievable compliance 
(Adeyemi, Olubunmi, & Oluseyi, 2011). In contrast to these findings, a number of studies 
have also reported that there is no significant association between stigma and HIV 
treatment adherence (Martinez et al., 2012; Kalichman et al., 2008).   
 Alcohol Use and HIV Treatment Adherence 
In addition to stigma and mental health problems, alcohol and drug use have been 
identified as important factors affecting HIV treatment adherence (Lucas, 2011). Alcohol 
use constitutes the most consistent and widespread barrier to HIV treatment adherence 
(Gonzalez, Barinas, & O’Cleirigh, 2011; Azar et al., 2010). Alcohol use is not only a 
significant cause of sub-optimal treatment adherence but also associated with worsening 
disease progression and compromised general well-being (Cook et al., 2001). It has been 
estimated that a quarter to half of all PLWH report moderate to higher levels of alcohol 
consumption, and many of them cross into the 'problem drinking' category defined as 
alcohol consumption "sufficiently large enough to lead to problems of health and social 
functioning, but do not necessarily meet Diagnostic and Statistical Manual of Mental 
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Disorders, Fourth Edition criteria for alcohol abuse or dependence" (Cooke et al., 2001 p. 
83). One study also reported that alcohol use was twice as common in those PLWH who 
reported cocaine or heroin use or reported lower educational status (Galvan et al., 2002). 
Several studies have reported that alcohol use alone or in combination with drug use have 
significantly decreased treatment adherence (Chander, Lau, & Moore, 2006; Cook et al., 
2001). In a study of PLWH with history of alcohol use problems, semiannual assessments 
over a period of 30 months revealed that alcohol consumption constituted the most 
significant predictor of treatment non-adherence (Samet et al., 2004). This study also 
showed that adherence rates were significantly lower in those who continued to use 
alcohol when compared to recent abstainers (Samet et al., 2004). Alcohol consumption 
during ART resulted in medication lapses, missed doses, and ultimately, treatment 
failures in many studies (Hendershot et al., 2009; Braithwaite et al.,2007). Additionally, 
alcohol use resulted in memory and cognitive impairments which further affected 
treatment compliance (Braithwaite et al., 2005). Excessive alcohol consumption also 
affected treatment adherence by delaying follow-up visits, prescription renewals and 
medication pick-ups (Kalichman et al., 2007; Sankar et al., 2007).    
 Coping and Resilience  
 Being seropositive is an inherently stressful situation with far reaching mental and 
psychosocial consequences (Kelly et al., 1998). As medical advances continue to prolong 
the lives of PLWH, there is a greater need for understanding the adaptation and coping 
mechanisms employed by these patients. When faced with situations of acute/ongoing 
stress or the challenges of stigma and discrimination, individuals engage in coping 
processes that include behavioral as well as psychological adaptations aimed at 
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overcoming the stressors or challenges (Taylor & Stanton, 2007). The coping processes 
involve efforts to tolerate or overcome the stressful and painful effects of particular 
events (Folkman & Lazarus, 1980). In the context of HIV infection, effective coping is 
said to require "conscious, purposeful behavior" which "determines the individual’s 
ability to live successfully with the continuous and chronic assault of HIV" (Fife et al., 
2008, p. 77). Studies have identified two general forms of coping: active (or approach 
coping) and passive (or avoidance coping; Moosa, Jeenah, & Vorster, 2005; Smith et al., 
2001).  Active coping involves directly engaging with situations via problem-solving, 
information seeking, and cognitive restructuring processes, whereas passive coping 
involves denial and avoidance (Kotzé, et al., 2013). 
 While either one or both of these coping mechanisms may be employed randomly 
or in tandem, studies show that subjects employing active approaches have greater 
success rates in adapting to stressors and hence report fewer negative effects compared to 
those relying solely on passive avoidance strategies (Kim et al., 2010).  Yeji and 
colleagues (2014), for example, found that one of the elements of avoidance coping 
strategies includes withdrawal from social contacts, which, in their study, increased the 
likelihood of depression. Other studies have similarly concluded that passive coping 
based on denial and avoidance is linked to higher rates of depression and even impaired 
treatment adherence (Lesserman et al., 1997). Passive coping has also been associated 
with increased sexual risk behaviors which could lead to increased transmission of the 
virus (Kelly et al., 1993). In contrast, a number of studies exploring coping mechanisms 
have found that active coping strategies improve quality of life (Vyavaharkar, 
Moneyham, Murdaugh, & Tavakoli, 2011), nurture higher self-esteem (Trevino et al., 
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2010; Stein & Rotheram-Borus, 2004) and develop more positive affect (Deichert et al., 
2008). Additionally, studies have also shown that active coping strategies have the 
potential to decrease psychological distress (Kraaij et al., 2008) and are associated with 
lower levels of substance use (Pence et al., 2008) and greater treatment adherence 
(Vervoort et al., 2009). Active coping is considered an adaptive or resilient strategy 
because it involves positive means of adaptation and enables beneficial recovery and 
resilience to significant stressors (Sinclair & Wallston, 2004). Because of these beneficial 
effects, many studies have recommended increasing our collective knowledge about 
active coping strategies among PLWH and understanding the factors and resources 
influencing these strategies (Earnshaw et al., 2013b).   
 Resilience refers to the capacity of positive adaptation and effective coping when 
faced with stressors and adversities (Connor & Davidson, 2003). The characteristics 
associated with resilience may be both individual (e.g. self-esteem, personality traits, 
coping style, spirituality, etc.) and social (e.g. supportive peer networks, relationship and 
support from family, friends etc.; Zhang et al., 2015). Among PLWH, stigma constitutes 
an important cause of stress, anxiety, panic and depression and PLWH are exposed and 
forced to cope with it. The notion of “resilience resources” was constructed to identify 
the modifiable and strength-based moderators that have effects on the coping 
mechanisms adopted by PLWH (Earnshaw et al., 2013b). Among these resources, social 
support and identity centrality constitute the two most crucial elements (Earnshaw, et al., 
2015; Pascoe & Smart Richman, 2009).   
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Social Support   
There is considerable literature about the fundamental role played by social 
support in improving mental and physical outcomes in PLWH (Degroote, Vogelaers, & 
Vandijck, 2014). Social support (Wallston, Alagna, DeVellis, & DeVellis, 1983) has 
been categorized into two broad domains: emotional/informational support (which 
includes the expression and exchange of positive feelings and emotions, particularly 
empathy, love, and trust) and instrumental/tangible support (which represents the more 
tangible forms, such as physical assistance or material goods and services; Earnshaw et 
al., 2015; Cho, Zunin, Chao, Heiby, & McKoy, 2012; Taylor, 2011; Heaney & Israel, 
2008). Both of these social support components, emotional/informational support and 
instrumental/tangible social support, are identified as key resilience resources that 
moderate the relationship between stigma and stress (Earnshaw et al., 2015). Social 
support has been shown to reduce depression in PLWH (Asante, 2012; Vyavaharkar et 
al., 2011) and associated with lower levels of mental health problems (Lam, Naar-King, 
& Wright, 2007; McDowell & Serovich, 2007). The emotional/informational support 
received from family and friends contribute to the development of adaptive coping and 
improved treatment adherence among PLWH (McDowell & Serovich, 2007; Ware, 
Wyatt, & Tugenberg, 2006). Instrumental/tangible social support is particularly effective 
in coping with depression, improving treatment adherence, and retention in treatment 
facilities (Yeji et al., 2014). PLWH with greater access to instrumental/tangible social 
support experience less stigma-related stress which may ultimately protect them from 
adverse HIV symptoms (Earnshaw, 2015). In fact, Heywood and Lyons (2016) contend 
that any kind of support from any of the sources have significant beneficial effects on 
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PLWH. Despite evidence of the beneficial effects of social support, some studies contend 
that factors beyond social support affect the relationship between HIV stigma and mental 
health (Breet, Kagee, & Seedat, 2014). Supporting these contentions, some studies have 
also reported that there is no relationship between social support, stigma, stress and 
health outcomes (Logie et al., 2012; Pascoe & Smart Richman, 2009).   
Identity Centrality  
Identity theorists have suggested that selfhood is defined by multiple, shifting 
identities which function as internalized positional markers that reflect our participation 
in any structured role relationship (Stryker & Serpe, 1982). The various roles that we play 
over the course of our lives have significant impacts on our identities and amalgamate 
together to develop the self (Serpe, 1987). The salience of any given identity depends on 
the numbers, types, and strength of the social relationships associated with that identity, 
in the sense that the more a specific identity is invoked and enacted, the higher its 
salience (Serpe, 1987). Salience is closely related to another construct, “centrality”, 
which refers to the extent to which a particular identity defines an individual's sense of 
self and who they are as a person (Quinn & Earnshaw, 2011). For example, being 
diagnosed and living with HIV imposes an identity centrality that the affected person 
belongs to the HIV infected community. Some studies have postulated that the relative 
salience or centrality of HIV status, as a defining aspect of self, may have important 
implications for mental health and the coping strategies that individuals adopt as they 
deal with various forms of stigma (i.e. enacted, anticipated, internalized; Earnshaw, 2015; 
Baumgartner & Niemi, 2013). Significant research has been conducted on the processes 
and events that shape the formation of identity centrality for any specific individual 
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characteristic or trait. Among them, the identity centralities associated with gender and 
race constitute visible identities and can be molded to improve outcome variables such as 
treatment adherence, coping mechanisms, and resilience (Jamil, Harper, & Fernandez, 
2009; Phinney & Chavira, 1992). Gender and race identities are associated with 
biological and developmental processes and constitutes stronger identities with beneficial 
roles. Many studies have also shown that harnessing such visible central identities 
improved mental health outcomes in PLWH (Mossakowski, 2003; Earnshaw, 2015). 
However, belonging to the HIV community does not generate a visible central identity as 
observed in gender and race, but instead produces a concealable stigmatized identity 
(CSI) (Quinn et al., 2014). Some studies have demonstrated that CSI is associated with 
higher levels of distress and discomfort (Quinn & Chaudoir, 2009). The effects of HIV 
identity as a CSI are questionable due to extremely sparse research on this topic. 
Irrespectively, Harper and colleagues (2013) have proposed that a salient or centralized 
HIV identity may be associated with detrimental effects such as poor treatment 
adherence. They propose that when PLWH strongly identify with their HIV status, they 
become overwhelmed and experience a range of negative emotions that adversely affect 
treatment adherence (Harper et al., 2013). Due to the lack of rigorous and conclusive 
studies on identity centrality in HIV, conclusions regarding its effects on PLWH are 
questionable. Nevertheless, it is an important factor because development of an HIV 
identity impacts the salience of other identities and has far reaching implications on the 
overall process of making sense of the challenging experience and developing adaptive 
coping strategies (Baumgartner & Niemi, 2013).    
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Summary  
 The subsections of this review (HIV stigma, treatment adherence, social support, 
coping, depression and anxiety) represent a broad range of significant issues in the 
current field of HIV research. While there is substantial evidence to the hypotheses 
explored in this dissertation, contradictions exist in a number of key areas. In regards to 
the association between HIV and depressive disorders, for example, a majority of the 
studies demonstrated a clear relationship, and yet some studies report that HIV status was 
not associated with depression (Kelly et al., 1998; Rabkin, et al., 1997). Similarly, in 
regards to stigma and mental health, some studies have challenged the mediating role of 
social support in the relationship between HIV-related stigma and mental health (Breet, 
Kagee, & Seedat, 2014). The relationship between internalized HIV stigma and 
medication adherence ranges from inversely strong (Rao et al., 2012; Sayles et al., 2007) 
to weak or no associations (Kalichman et al., 2008). The diversity in the strength of 
association between different outcome variables observed in different studies as well as 
the approaches, methodologies, and sampling contexts used across the literature suggest 
the need for further investigations. These investigations should be directed towards the 
intersections and interactions of multiple, simultaneously active components of HIV 
stigma, treatment adherence, social support, coping, depression and anxiety and their 
collective role in HIV care and well-being. 
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CHAPTER III: Relationship between HIV-Related Stigma and Treatment 
Adherence and the Mediating Effects of Coping Strategies in Alcohol Using PLWH 
in Haiti 
Introduction 
Advancements in HIV-related treatment and care have significantly improved and 
extended the lives of people living with HIV (PLWH) (Bor, Herbst, Newell, & 
Bärnighausen, 2013). Despite these medical advances, progress in the social sphere has 
been very limited. Stigma, the social phenomenon involving labeling, stereotyping, and 
discrimination has been identified as one of the primary barriers to the provision of 
adequate care and support for PLWH (Morris et al., 2014) 
 The social stigma associated with HIV continues to exact devastating 
consequences on its victims (Tsai, 2013). Research shows that HIV-related stigma is far 
more intense when compared to the stigmas associated with other illnesses such as 
herpes, cancer, tuberculosis etc. (Earnshaw & Kalichman, 2013). HIV-related stigma has 
significant effects not only on the diagnosed individuals, but also their family members, 
their health workers and volunteers (Ha, Chuc, Hien, Larsson, & Pharris, 2013; Bogart et 
al., 2008). HIV-related stigma has been associated with broader social inequalities, 
becoming further entrenched by the compounded layering of existing stigmas related to 
drug use, and homosexuality (Reidpath & Chan, 2005; Takács, Kelly, P Tóth, Mocsonaki 
& Amirkhanian, 2013; Rudolph et al., 2012; Onyebuchi-Iwudibia & Brown, 2014). HIV- 
related stigma experiences are consistently associated with poor mental and physical 
health outcomes - including anxiety and depression, increased risky sexual behaviors, 
lower self-esteem, lower CD4 counts and higher levels of viral load (Bunn, Solomon, 
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Miller, & Forehand, 2007; Storholm et al., 2013; Earnshaw, Smith, Chaudoir, Amico, & 
Copenhaver, 2013; Holzemer et al., 2007; Preston, D'Augelli, Kassab, & Starks, 2007). 
Though many distinct forms of HIV-related stigma have been identified, perceived 
stigma has been associated with significant adverse effects in PLWH (Earnshaw & 
Chaudoir, 2009). Those experiencing higher levels of perceived stigma are at increased 
risk of transmitting their infection to others, and display elevated levels of depression, 
anxiety, and helplessness (Lee, Kochman, Sikkema, 2002; Earnshaw, Bogart, Dovidio & 
Williams, 2013).  
 Given the well documented negative effects of stigma experiences among PLWH, 
coping mechanisms have become a focus of substantial research. Coping has been 
defined as ongoing behavioral and cognitive efforts to manage and overcome taxing 
demands connected to stressful, painful, and difficult situations (Chida & Vedhara, 
2007). Coping has been conceptualized as a crucial process mediating the antecedent and 
subsequent outcomes of psychological stress. While multiple categories of coping 
strategies have been identified, the two most common groupings are adaptive coping 
(directly engaging with situations via problem-solving, information seeking, cognitive 
restructuring, etc.) and maladaptive coping (engaging in denial and avoidance; Kotzé, 
Visser, Makin, Sikkema & Forsyth, 2013). Studies consistently show that adaptive 
coping strategies result in more positive outcomes, including higher quality of life, self-
esteem, decreased psychological distress, lower frequency of substance use, and greater 
treatment adherence (Vervoort et al., 2009; Vyavaharkar et al., 2011; Trevino et al., 
2010; Kraaij et al., 2008; Pence et al., 2008). In contrast, maladaptive coping leads to 
poor quality of life, higher anxiety, decreased physical functioning, and greater 
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psychological distress (Kraaij et al., 2008; Brook & Willoughby, 2016; Ferreira-Valente, 
Pais-Ribeiro & Jensen, 2014; Joyce et al., 2015). Maladaptive coping also predicts faster 
disease progression and could affect mortality (McIntosh et al., 2015).  
 The relationship between HIV related stigma, coping and treatment adherence is 
extremely relevant because many studies have recommended moderate to high levels of 
treatment adherence in order to ensure adequate control over the disease (Kobin & Sheth, 
2011; Parienti et al., 2008; Shuter, Sarlo, Kanmaz, Rode & Zingman, 2007). Treatment 
non-adherence can result in uncontrolled viral load, (increasing the risk of sexual 
transmission), non-recuperating CD4 counts (faster progression to AIDS), and significant 
drug resistant viral strains (Weiser, Palar, Frongillo, Tsai & Kumbakumba, 2014; 
Nachega et al., 2011). Therefore, understanding the factors affecting treatment adherence 
is crucial. Treatment adherence is influenced by a range of psycho-social factors. Some 
of the factors influencing HIV treatment adherence include: memory; adverse effects of 
medications; regimen complexity; domestic responsibilities; availability and access to 
medications; existing comorbidities; psychiatric problems such as depression and 
anxiety; and subjective knowledge and awareness about the disease (Kardas, Lewek & 
Matyjaszczyk, 2013). Stigma and coping mechanisms are important psycho-social factors 
affecting treatment adherence in PLWH (Lyimo et al., 2014). In a study by Rintamaki 
and colleagues (2006), it was observed that participants experiencing higher levels of 
stigma were 3.3 times more likely to report sub-optimal treatment adherence. Similarly, a 
meta-analysis done by Katz et al. (2013), reports that stigma undermines social support 
and adaptive coping and thus compromises treatment adherence among PLWH. Thus, 
stress, social isolation, and diminished view of self that result from perceived stigma have 
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many negative repercussions when it comes to adhering to prescribed medical treatment 
for HIV. Furthermore, coping mechanisms have the potentials to alleviate many of these 
repercussions. Clearly, HIV-related stigma, coping strategies, and adherence intersect in 
complex and mutually consequential ways. This study, therefore, aims to clarify the 
relationships among these factors by exploring their effects within HIV positive alcohol 
users living in Haiti. The study also examined the association between health care 
satisfaction and treatment adherence, which is an important individual-level factor in the 
clinical setting which could affect treatment adherence. 
Methods 
Study Design and Population  
The current study utilized a secondary analysis of data from the parent study 
titled, “Intervening with Haitian HIV positive Alcohol Users: An Environmental 
Psychosocial Framework.” The parent study was a randomized controlled trial that 
examined the effectiveness of the adapted CBSM-A intervention in simultaneously 
reducing risk behaviors, improving ART adherence and mood.  Participants were 
provided information on HIV disease and its treatment, including currently available 
ART medications, the negative effects of substance use and high-risk sexual behavior on 
the immune system and health status, and the nature of stress, coping responses and 
resources. The skill building aspects of the parent study included: teaching anxiety 
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics; 
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing 
interpersonal conflict resolution skills and anger expression via anger management and 
assertion training; and providing a supportive group environment and increasing 
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utilization of social support networks. Data collection for the parent study occurred at the 
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections 
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed 
to include a combination of problem-focused (e.g., active coping and planning) and 
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.  
  The parent study included participants who were: between 18 and 60 years of age; 
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one 
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol 
consumption; were not cognitively impaired at the time of recruitment; and did not show 
symptoms of any major psychiatric disorder. The current study included subjects who 
participated in baseline assessments before the beginning of randomization and 
intervention. The institutional review board (IRB) at Florida International University 
approved this secondary analysis study in September, 2015.  
Measures 
HIV Treatment Adherence  
HIV treatment adherence was measured using the Community Programs for 
Clinical Research on AIDS (CPCRA) Antiretroviral Medication Self-Report 
questionnaire (Form 646; Terry Beirn Community Programs for Clinical Research on 
AIDS, 2003; see Appendix II). This questionnaire uses a global 7-day recall and has slots 
for recording drug name, drug code, number of pills per dose, number of doses per day, 
and total number of pills per day. For each of the prescribed medications, the 
questionnaire records whether the patients took “all,” “most,” “about half,” “very few,” 
or “none” of their pills during the preceding seven days. Adherence to each medication is 
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calculated based on the percentages assigned to each of these responses, which include: 
“all” (100%); “most” (80%); “about half” (50%); “few” (20%); and “none” (0%). Total 
adherence is calculated as the mean of the total scores of all the individual medications 
and constitutes a continuous variable ranging from 0-100 percent. In this study, 
participants were categorized into those who reported ≥95% adherence to all medications 
(high treatment adherence) and those who reported <95% treatment adherence (low 
treatment adherence). Previous studies have reported ≥95 % adherence rates as ideal 
treatment adherence (Mannheimer et al., 2006).  
The questionnaire also includes a checklist of ten possible reasons why the 
antiretroviral doses were missed, which include: side effects; pill burden; forgetfulness; 
being away from home; concerns about confidentiality; difficulties with dietary 
requirements; and confusion. However, these questions could be asked to only those 
participants who reported missed medications. Therefore, in this study, descriptive 
statistics were used to understand the reasons for non-adherence. 
Stigma of HIV/AIDS  
HIV/AIDS related stigma was measured using the Perceived Stigma of 
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman, 
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale 
measures stigma in terms of two components – internalized stigma and externalized 
stigma. In order to measure these two parameters, the questionnaire includes two 
subsections – personal view and public view. The personal view subscale includes 
questions related to shame, guilt, blame, embarrassment, and poor self-worth due to HIV. 
The public view subscale includes questions related to participant’s perception about 
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social stigma, for example, what the respondent thinks about other people's attitudes and 
beliefs towards his/her disease condition. The questions in the subscales are both 
positively and negatively phrased to increase the specificity of the responses. Both 
subscales have 24 questions measured on a four-point Likert-type scale (1 = strongly 
agree to 4 = strongly disagree). The total score of each subscale ranges between 24 and 
96 and higher scores represent higher levels of stigma. Cronbach’s alpha of the 
instrument was 0.869.   
Coping  
Coping strategies were measured using the Brief COPE questionnaire (Carver, 
1997; see Appendix IV). The Brief COPE questionnaire includes 28 questions classified 
into 14 components with two questions per component. Each question is measured using 
a 4-point scale (1 = I have not been doing this at all; 2 = I've been doing this a little bit; 3 
= I've been doing this a medium amount; and 4 = I have been doing this a lot). The 14 
components include: self-distraction, active coping, denial, substance use, use of 
emotional support, use of instrumental support, behavioral disengagement, venting, 
positive reframing, planning, humor, acceptance, religion, and self- blame. Based on 
evidence that these factors tend to be either generally adaptive or problematic, the 14 
components are further classified into two domains: adaptive coping or maladaptive 
coping (Carver, 1997). The adaptive coping domain contains eight components with 
possible scores of 0 to 48, and higher scores signify greater levels of adaptive coping. 
This domain includes the following components: active coping, planning, positive 
reframing, acceptance, humor, religion, using emotional support, and using instrumental 
support. The maladaptive coping domain contains six components with possible scores of 
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0 to 36, and higher scores signify greater levels of maladaptive coping. This domain 
includes the following components: self-distraction; denial; venting; substance use; 
behavioral disengagement; and self-blame. Cronbach’s alpha of the instrument was 
0.907.   
Satisfaction with the Quality of Care 
Satisfaction with quality of care received by the participants was assessed by 
asking, “How satisfied were you with the quality of care you received at the visit?” and 
measured using a 4-point scale (1 = very satisfied; 2 = satisfied; 3 = unsatisfied; and 4 = 
very unsatisfied). 
Data Analyses 
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures 
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.). 
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests 
were used to describe the demographic characteristics. Independent samples t tests were 
used to compare perceived stigma and coping variables between those reporting low 
versus high treatment adherence. In addition, the reasons for non-adherence to 
medications were described using percentages among participants with less than 
complete (<100%) treatment adherence. Pearson correlations were used to find 
associations between treatment adherence, and the domains of perceived stigma (personal 
view and public view), coping variables (adaptive coping and maladaptive coping), and 
satisfaction with quality of care scores. Multivariable linear regressions were used to 
estimate the predictors of treatment adherence with demographics, stigma and coping 
domains and satisfaction with quality of care scores as independent variables. In the 
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regressions analysis, crude models were used initially and subsequently adjusted for 
associated covariates. The covariates were also tested for significant associations with the 
outcome variable using bivariate analysis before being incorporated into the final model. 
To increase the validity of the model, multicollinearity among covariates was tested prior 
to regression analyses. Adjusted models included non-missing values for all independent 
variables included in the models. Structural equation modeling (SEM) was used to test 
the hypothesis of whether the relationship between stigma and HIV treatment adherence 
variables were mediated by coping variables. SEM accounts for multiple interactive 
relationships and variances and explores for directional associations between them 
leading to delineation of the mediators (Grimm & Yarnold, 2000; Kline, 1998). In the 
analysis, maximum-likelihood estimation was used for the AMOS modules. Statistical 
significance was set at p <0.05 for all the analyses.   
Results  
Demographic and socio-economic characteristics 
A total of 285 participants who reported taking medications were included in the 
secondary analyses and 122 (42.8%) were men (Table 1). The mean age of the cohort 
was 36.43±8.62 (Mean±SD) years. About 59% of the participants had a 6th grade or less 
education. Approximately 60% reported that they were married and about 59.2% were 
unemployed. The majority of the participants reported having primary care physicians 
(91.2%).  
Stigma and HIV treatment adherence 
Participants with higher HIV treatment adherence reported significantly lower 
levels of perceived stigma scores (p = .049; Table 2). However, there were no significant 
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differences between low versus high treatment adherence with respect to perceived 
stigma-personal view and perceived stigma-public view. Satisfaction with quality of care 
scores were significantly greater in those reporting high adherence to treatment. There 
was also significant difference in age, educational levels and marital status between those 
reporting low versus high treatment adherence.   
Coping scores and HIV treatment adherence 
 There were no significant differences in total coping scores between participants 
reporting higher versus lower treatment adherence (Table 3). However, with respect to 
total maladaptive coping scores, participants reporting low treatment adherence scored 
significantly higher than participants reporting high treatment adherence (p = .021). 
Similarly, with respect to the individual components of maladaptive coping, substance 
use (p = .018) and behavioral disengagement (p = .011), the low treatment adherence 
group scored significantly higher. However, with respect to the individual components of 
adaptive coping, use of instrumental support (p = .047), the high treatment adherence 
group scored significantly higher.  
Reason for not taking medication  
 A significant number of participants (48.8%) reported problems taking pills at 
specified times (Table 4). This was followed by forgetting to take the pills (42.5%) and 
not wanting others to notice taking medications (38.8%).   
Relationship between adherence, perceived stigma, coping and satisfaction 
Significant negative correlations were observed between treatment adherence, and 
total perceived stigma (r = -.119, p <0.05), and maladaptive coping domain of coping 
strategies (r = -.129, p <0.05). Irrespective of the associations between treatment 
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adherence and total perceived stigma, the individual domains of perceived stigma –  
personal view and public view – did not show any association with treatment adherence. 
Total coping scores also did not show any significant association with treatment 
adherence. Significant positive correlations were observed between treatment adherence 
and satisfaction with quality of care scores (r = .157, p <0.01; Table 4). 
Predictors of HIV treatment adherence 
In the adjusted multivariable linear regression model perceived stigma (Beta = -
.049, p = .031), showed significant negative associations with treatment adherence, 
whereas, satisfaction with quality of care scores (Beta = .032, p = .041) showed positive 
association with treatment adherence. However, there were no associations between 
maladaptive coping and treatment adherence. 
Mediation analysis 
In the mediation analysis, coefficients were simultaneously estimated for all the 
variables that showed significant associations in bivariate analyses including treatment 
adherence, perceived stigma and maladaptive coping. However, there were no significant 
association between these variables in the mediator analyses. Figure 1 shows the path 
diagram for these variables. In this model, there were significant negative associations 
between perceived stigma and treatment adherence (Beta = -.208, p = .016) and 
maladaptive coping and treatment adherence (Beta = -.180, p = .037). However, there 
were no associations between perceived stigma and maladaptive coping (Beta = .029, p = 
.740). These observations suggest that the effect of stigma on HIV treatment adherence is 
not mediated by maladaptive coping.   
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Discussion  
Results of this study show that perceived stigma and quality of care satisfaction 
scores were significant predictors of HIV treatment adherence among alcohol using 
PLWH in Haiti. Mediation analyses, however, showed that maladaptive coping did not 
act as a mediator between perceived stigma and treatment adherence. This could be due 
to the stronger effects of perceived stigma on treatment adherence.  
The mean adherence in this study was 93.1%, and this included 100% adherence 
reported by 71.9% of the cohort. About 72.3% of the participants reported ≥95% 
adherence. This is comparable to many other studies done among PLWH in similar 
resource limited settings. For example, in a Ugandan study done by Byakika-Tusiime and 
colleagues (2005), > 95% adherence was reported by 68% of the participants. Likewise, a 
study in Senegal reported 91% adherence for all participants (Lanièce et al., 2003). 
Achieving higher levels of adherence to a remarkably complex regimen is not only 
challenging but also demanding for both patients and caregivers (Johnson, Heckman, 
Hansen, Kochman & Sikkema, 2009; Murphy, Roberts, Martin, Marelich & Hoffman, 
2000). Despite meticulous efforts by healthcare professionals, PLWH continue to miss 
doses, misinterpret medication schedules and misrepresent adherence levels (Gust et al., 
2011). The high levels of adherence observed in this study could be attributed to the 
meticulous efforts done by the staff at the GHESKIO centers in Haiti.  
The finding that treatment adherence was inversely associated with perceived 
stigma scores is consistent with many other studies done in other PLWH populations. For 
example, in a cross-sectional study of 204 American PLWH, adherence measured 
through Patient Medication Adherence Questionnaire (PMAQ) was inversely associated 
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with internalized stigma and disclosures of HIV status (Waite, Paasche-Orlow, 
Rintamaki, Davis & Wolf, 2008) Similarly, in a South African study, adherence 
measured through ACTG Adherence Instrument was adversely associated with fear of 
stigma (Spire et al., 2002). In this study, though the total perceived stigma scores showed 
significant negative associations with treatment adherence, there were no associations 
between the two domains of total perceived stigma – personal view and public view – 
and treatment adherence.    
In this study, maladaptive coping was not associated with treatment adherence. 
However, in a previous study done in the same population, Malow et al. (2013), reported 
that maladaptive coping indirectly affected treatment adherence through mediating 
variables such as greater depression and negative attitudes about medications. However, 
in the current study we did not measure depression and negative attitudes about 
medications, thereby limiting the conclusions of this study. Irrespective of these findings, 
a number of studies reported that maladaptive coping was associated with adverse 
outcomes in HIV including treatment adherence. In a study by McIntosh et al. (2015), 
maladaptive coping was associated with higher rates of disease progression and faster 
occurrence of AIDS symptoms. Maladaptive coping was also associated with increased 
sexual risk behaviors which could lead to higher disease transmission rates (Sánchez, 
Rice, Stein, Milburn & Rotheram-Borus, 2010). In a study by Johnson and colleagues 
(2009), maladaptive coping had significant adverse effects on social support variables 
such as social well-being, and support from family/friends which contributed to negative 
effects such as depression, anxiety and lower psychological well-being scores, which in 
turn indirectly affected adherence to ART. 
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 In the current study, there were positive associations between quality of care 
satisfaction scores and treatment adherence. Similarly, in a study done by Martinez et al. 
(2012), health care satisfaction significantly moderated (alleviated) the adverse effects of 
stigma on treatment adherence and the effects strengthened over time. Many other studies 
have demonstrated the beneficial effects of health care satisfaction on treatment 
adherence (Bennett, Fuertes, Keitel & Phillips, 2011; Martinez et al., 2012; Barbosa, 
Balp, Kulich, Germain & Rofail, 2012). Satisfaction with heath care is associated with 
trusting, positive, and working relationships between patients and health care providers 
including availability during times of urgency, needs and illness (Urowitz & Deber, 
2008). Some of the factors associated with improved health care satisfaction scores 
include comprehensiveness, competence, continuity of care, consistency, and compassion 
demonstrated by the health care personnel during clinical encounters (Williams & 
Friedland, 1997). 
In this study, the two most common reasons for non-adherence included inability 
to comply with complex medication schedules and forgetfulness. Both of these reasons 
have been identified as common causes for nonadherence in many studies (Adefolalu & 
Nkosi, 2013; Byakika-Tusiime et al., 2005). Some of the reasons for forgetting their 
medications include frequent residential changes, changes in living patterns, or travelling 
for a living (Vervloet, 2012). Some studies have suggested the beneficial effects of 
adherence counseling in providing assistance to PLWH in terms of follow-up visit 
reminders, treatment diaries, pill boxes and alarmed pill bottles. For example, in a study 
among female PLWH in Kenya, adherence significantly improved with such efforts 
(Frick, Lavreys, Mandaliya & Kreiss, 2001).  
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 There were some limitations to this study. The study participants were recruited 
from the GHESKIO centers, which provide comprehensive health care services, free of 
charge, to socioeconomically underprivileged communities in Haiti. Participants in this 
study could have differed significantly from PLWH who have limited access to the 
GHESKO centers due to several structural barriers. Thus, the results of this study cannot 
be generalized to the entire population of PLWH from Haiti. The current study was a 
secondary analysis of baseline data collected for the parent study. This could have caused 
some surrogate information biases in the current study. The data is self-reported, and 
participants were HIV positive alcohol users, which may increase recall bias and social 
desirability biases could have affected the findings of this study. Because of the cross-
sectional nature of the study, causal associations could not be determined and because of 
lack of HIV-negative comparison group the effects of other confounders could not be 
eliminated.  
Conclusion 
PLWH experience considerable levels of internalized and externalized stigma to 
which they react using coping strategies. In this cross-sectional study of HIV positive 
alcohol users in Haiti, we found that perceived stigma was adversely associated with 
treatment adherence, whereas health care satisfaction was positively associated with 
treatment adherence. These findings suggest that adherence enhancing interventions 
should consider HIV-related stigma and health care satisfaction levels. Additional factors 
such as difficulty following complicated schedules, forgetfulness and confidentiality for 
medications should be addressed in such interventions.  
 
 74 
 
Acknowledgements  
I would like to thank Dr. Jessy G. Dévieux, my major professor, for providing 
access to the parent study data repository, as well as her entire research group especially 
Dr. Michele Jean-Gilles for heling me extracting the data. I would also like to thank Dr. 
H. Virginia McCoy, Dr. Consuelo M. Beck-Sagué, and Dr. Florence George for the 
intellectual content of this manuscript. I acknowledge the valuable support provided by 
the University Graduate School, Florida International University, in terms of Doctoral 
Year Fellowship. Above all, I am very grateful to the GHESKIO Centers, Port-au-Prince, 
Haiti, who collaborated enthusiastically for this project. 
 75 
 
Table 3.1. Demographic characteristics of the participants 
Characteristics HIV treatment adherence p value Total 
(n=285, 
100%) 
Low 
(n=79, 
27.7%) 
High 
(n=206, 
72.3%) 
Age* 34.46±8.05 37.23±8.75 .015 36.43±8.62 
Gender   .307  
 Male 30 (38.0%) 92 (44.7%)  122 (42.8%) 
 Female 49 (62.0%) 114 (55.3%)  163 (57.2%) 
Education*   .022  
 6th grade or less 36 (48.0%) 127 (63.2%)  163 (59.1%) 
 Some high school or 
higher 
39 (62.0%) 74 (36.8%)  113 (40.9%) 
Marital status**   .009  
 Single or living as 
single 
41 (51.9%) 72 (35.0%)  113 (39.6%) 
 Married 38 (48.1%) 134 (65.0%)  172 (60.4%) 
Employment   .286  
 Full time job 1 (2.0%) 4 (3.7%)  5 (3.2%) 
 Seasonal job 11 (22.4%) 27 (25.0%)  38 (24.2%) 
 Unemployed 28 (57.1%) 65 (60.2%)  93 (59.2%) 
 Student 3 (6.1%) 1 (0.9%)  4 (2.5%) 
 Incapacitated 1 (2.0%) 0 (0%)  1 (0.6%) 
 Other 5 (10.2%) 11 (10.2%)  16 (10.2%) 
Income   .857  
 <$150 9 (30.0%) 25 (26.0%)  34 (27.0%) 
 $151-1,000 10 (33.3%) 37 (38.5%)  47 (37.3%) 
 >$1,000 11 (36.7%) 34 (35.4%)  45 (35.7%) 
Primary care   .151  
 Yes 69 (87.3%) 191 (92.7%)  260 (91.2%) 
 No 10 (12.7%) 15 (7.3%)  25 (8.8%) 
Satisfaction with quality 
of care* 
3.12±0.89 3.36±0.04 .016 3.29±0.73 
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact 
test 
*p<.05; **p<.01; ***p<.001 
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Table 3.2. Participants’ stigma by level of HIV treatment adherence 
Stigma HIV treatment adherence p value Total 
Low High 
Personal  54.82±7.96 54.48±8.25 .752 54.57±8.13 
Public 54.75±9.29 54.02±10.62 .592 54.15±10.30 
Total 109.58±14.64 108.24±17.55 .049 108.54±16.79 
*p<.05; **p<.01; ***p<.001
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Table 3.3. Participants’ Brief COPE scores by level of HIV treatment adherence 
Brief COPE HIV treatment adherence p value Total 
Low High 
Adaptive coping 
Positive reframing 5.06±1.79 5.00±1.76 .815 5.02±1.77 
Use of instrumental support* 4.75±1.64 5.21±1.95 .047 5.12±1.88 
Religion 5.80±1.61 5.95±1.71 .502 5.94±1.68 
Use of emotional support 4.92±1.80 4.87±1.73 .850 4.90±1.75 
Acceptance 5.18±1.65 4.98±1.66 .375 5.03±1.65 
Planning 5.44±1.52 5.32±1.67 .568 5.36±1.62 
Active coping 5.36±1.73 5.08±1.81 .241 5.16±1.80 
Humor 4.81±1.67 4.73±1.79 .742 4.77±1.76 
Total adaptive coping 41.35±8.82 41.18±9.31 .892 41.33±9.16 
 
Maladaptive coping 
Self-distraction 5.23±1.78 4.78±1.73 .054 5.02+1.78 
Denial 5.17±1.60 4.92±1.84 .298 4.98±1.79 
Substance use* 5.13±2.25 4.44±2.09 .018 4.65±2.15 
Behavioral disengagement* 5.92±1.90 5.24±1.95 .011 4.92±1.74 
Venting 5.15±1.76 5.05±1.80 .668 5.07±1.77 
Self-blame 5.23±1.78 4.78±1.73 .204 5.39±1.94 
Total maladaptive coping* 32.26±7.25 29.78±8.21 .021 30.44±7.99 
     
Total coping 73.61±14.76 70.97±15.80 .193 71.78±15.50 
*p<.05; **p<.01; ***p<.001 
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Table 3.4. Reasons for not taking medication by participants with low HIV treatment 
adherence 
Reason n (%) 
I feel worse when I take the pills 17 (21.3%) 
There are too many pills to take 15 (18.8%) 
I forget to take the pills 34 (42.5%) 
I ran out of pills 4 (5.0%) 
I don't think I need the pills 14 (17.5%) 
I was away from home 25 (31.3%) 
I did not want others to notice 31 (38.8%) 
I am too busy 18 (22.5%) 
I had problems taking pills at specified times (with 
meals, on empty stomach, etc.)  
39 (48.8%) 
I was confused or uncertain about how to take the pills 10 (12.5%) 
*p<.05; **p<.01; ***p<.001 
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Table 3.5. Correlation between adherence, perceived stigma, coping and satisfaction 
 1 2 3 4 5 6 7 8 
1. Adherence ---        
2. Personal view -.042 ---       
3. Public view -.106 .313** ---      
4. Perceived stigma -.119* .612** .703** ---     
5. Adaptive coping -.025 -.227** -.182** -.222** ---    
6. Maladaptive coping -.129* -.077 -.071 -.066 .632** ---   
7. Total coping -.081 -.174** -.144* -.165** .917** .889** ---  
8. Satisfaction .157** -.081 -.049 -.025 -.003 -.084 -.045 --- 
*p<.05; **p<.01; ***p<.001
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Table 3.6. Multivariable linear regression predicting depression 
Independent variables Estimate Standard 
error 
Beta p value 
Age 0.002 0.001 0.082 0.184 
Sex -0.007 0.024 -0.02 0.753 
Education -0.038 0.017 -0.142 0.921 
Marital status 0.044 0.023 0.113 0.061 
Satisfaction*  0.032 0.016 0.123 0.041 
Maladaptive coping -0.002 0.001 -0.091 0.133 
Stigma*  -0.049 0.023 -0.131 0.031 
*p<.05; **p<.01; ***p<.001 
Adjusted R-squared value = .24
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Figure 3.1. Path diagram to describe the interrelationship between HIV related stigma, 
coping and HIV treatment adherence 
 
  
*p<.05; **p<.01; ***p<.001 
 
 
 
Maladaptive 
Coping 
Adherence 
-.21* 
.03 -.18* 
Perceived stigma 
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CHAPTER IV: Effects of Stigma and Anxiety on Treatment Adherence with 
Maladaptive Coping as Mediator among HIV-Positive Alcohol Users in Haiti 
Introduction  
HIV is a global health problem, and despite significant advancements in treatment 
and prevention strategies, it remains one of the most stigmatized diseases worldwide. 
Among PLWH, stigma contributes to considerable emotional and psychological distress 
(Stutterheim et al., 2011) and acts as one of the greatest barriers to adequate treatment 
and control (Katz, et al., 2013). As a social and structural phenomenon involving 
stereotyping, status loss, and discrimination, stigma represents a significant risk factor for 
mental health problems among PLWH (Mahajan et al., 2008; Earnshaw & Chaudoir, 
2009). HIV-related stigma has been consistently associated with increased anxiety, 
depression, PTSD, alcoholism, drug use and other psychiatric disorders (Dévieux et al., 
2013; Kamen et al., 2015; Yi et al., 2015).  
There are several studies which show that PLWH experience greater levels of 
dysfunctional personality and negative affective disorders (Olley, et al., 2015; Houston, 
Sandfort, Watson, & Caton, 2013). There are three streams of empirical evidence that 
associate HIV/AIDS with affective disorders. The first stream of evidence consists of 
studies that demonstrate remarkably higher levels of stress in PLWH (McIntosh & 
Rosselli, 2012; Kalichman & Grebler, 2010). These stressors are associated with 
physical, social, and medical aspects of the disease itself (Orban et al., 2010). The second 
stream of evidence comes from studies which show that PLWH additionally experience 
higher levels of life stressors not directly related to the disease. For example, abuse 
history, domestic violence, and poor socioeconomic status (Jewkes, Dunkle, Nduna & 
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Shai, 2010). The third stream of evidence comes from studies which show that PLWH 
inherently have increased susceptibility to psychiatric disorders due to unknown factors 
when compared to HIV-negative individuals within the same populations (Mayston, 
Kinyanda, Chishinga, Prince & Patel, 2012). Though the associations between HIV and 
anxiety have been relatively less documented when compared to other psychiatric 
disorders, a few studies have shown significant associations between HIV infection and 
post-traumatic stress disorders, generalized anxiety disorders, and panic disorders 
(Vranceanu et al., 2008; Myer et al., 2008). This evidence shows that there is a greater 
need to address anxiety disorders especially in a resource-limited nation like Haiti.  
Coping is defined as efforts to deal with demands taxing or exceeding the 
resources of the person (Lazarus & Folkman, 1984). Coping includes constant behavioral 
and cognitive efforts to manage and overcome the stressful demands connected to 
traumatic, painful, or difficult situations (Chida & Vedhara, 2007). Ever since the 
emergence of the epidemic, a number of studies have documented the beneficial effects 
of coping on stress and illness (McIntosh & Rosselli, 2012). Folkman (1997) 
demonstrated that coping mechanisms were associated with positive mind states in 
PLWH. Though several types of coping have been identified in the literature, two forms 
predominate – adaptive coping and maladaptive coping. Adaptive coping includes direct 
engagement strategies such as problem-solving, information seeking, and cognitive 
restructuring, whereas maladaptive coping includes patterns of denial and avoidance 
(Kotzé, et al., 2013). Adaptive coping is a resilient strategy because it involves positive 
means of adaptation and enables beneficial recovery and recuperation (Sinclair & 
Wallston, 2004). Research in this area also concludes that the meaning ascribed to HIV 
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varies between individuals and so various coping strategies may be differentially 
effective. Thus, coping interventions for PLWH may be most effective when tailored to 
individual life contexts and appraisals of PLWH with respect to their disease (Moskowitz 
& Wrubel, 2005). 
Many studies have recommended moderate to high levels of treatment adherence 
in order to ensure adequate control over the disease (Kobin & Sheth, 2011; Parienti et al., 
2008; Shuter et al., 2007). Treatment non-adherence can result in uncontrolled viral load, 
(increasing the risk of sexual transmission), non-recuperating CD4 counts (faster 
progression to AIDS), and significant drug resistant viral strains (Weiser, Palar, 
Frongillo, Tsai & Kumbakumba, 2014; Nachega et al., 2011). Therefore, understanding 
the factors affecting treatment adherence is crucial. A number of studies have shown 
adverse associations between anxiety disorders and treatment adherence in PLWH 
(Springer, Dushaj & Azar, 2012). Given the consequential effects of stigma and coping 
mechanisms on anxiety disorders and their combined effects on treatment adherence, the 
current study aims to explore these associations in a sample of HIV positive alcohol users 
in Haiti. 
Methods  
Study Design and Population  
The current study was a secondary analysis of data from the parent study titled, 
“Intervening with Haitian HIV positive Alcohol Users: An Environmental Psychosocial 
Framework.” The parent study was a randomized controlled trial that examined the 
effectiveness of the adapted CBSM-A intervention in simultaneously reducing risk 
behaviors, improving ART adherence, and mood.  Participants were provided 
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information on HIV disease and its treatment, including currently available ART 
medications, the negative effects of substance use and high-risk sexual behavior on the 
immune system and health status, and the nature of stress and coping responses and 
resources. The skill building aspects of the parent study included: teaching anxiety 
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics; 
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing 
interpersonal conflict resolution skills and anger expression via anger management and 
assertion training; and providing a supportive group environment and increase utilization 
of social support networks. Data collection for the parent study occurred at the 
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections 
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed 
to include a combination of problem-focused (e.g., active coping and planning) and 
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.  
  The parent study included participants who were: between 18 and 60 years of age; 
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one 
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol 
consumption; were not cognitively impaired at the time of recruitment; and did not show 
symptoms of any major psychiatric disorder. The current study included subjects who 
participated in baseline assessments before the beginning of randomization and the 
interventional The institutional review board (IRB) at Florida International University 
approved this secondary data analysis study in September, 2015.  
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Measures 
State Anxiety 
State anxiety was assessed using the State-Trait Anxiety Inventory (STAI), Form 
Y-1 (Spielberger, Gorsuch & Lushen, 1970; see Appendix V). STAI has two sections – 
Form Y-1 and Form Y-2. The first section of the inventory (Form Y-1) includes 20 
questions which measure transitory state anxiety levels in terms of a 4-point Likert scale 
(1 = not at all; 2 = somewhat; 3 = moderately so; and 4 = very much so). The total state 
anxiety scores are obtained by adding the scores for each of the 20 questions and range 
between 20 and 80. Higher scores signify greater levels of state anxiety. A cutting point 
of 39-40 has been suggested to indicate clinically significant symptoms for the state 
anxiety scale (Knight et al., 1983; Addolorato et al., 1999). The second section of the 
inventory (Form Y-2) also includes 20 questions which measure long term trait anxiety. 
However, trait anxiety levels change over extremely long periods of time and cannot be 
used for relatively short studies (Julian, 2011). The parent study did not measure trait 
anxiety levels due to the same reason. Cronbach’s alpha of the instrument was 0.744.   
Stigma of HIV/AIDS  
HIV/AIDS related stigma was measured using the Perceived Stigma of 
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman, 
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale 
measures stigma in terms of two components – internalized stigma (personal view) and 
externalized stigma (public view). In order to measure these two parameters, the 
questionnaire includes two subsections – personal view and public view. The personal 
view subscale includes questions related to shame, guilt, blame, embarrassment, and poor 
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self-worth due to HIV. The public view subscale includes questions related to 
participant’s perception about social stigma, for example, what the respondent thinks 
about other people's attitudes and beliefs towards his/her disease condition. The questions 
in the subscales are both positively and negatively phrased to increase the specificity of 
the responses. Both subscales have 24 questions measured by four-point Likert-type scale 
(1 = strongly agree to 4 = strongly disagree). The total score of each subscale ranges 
between 24 and 96 and higher scores represent higher levels of stigma. Cronbach’s alpha 
of the instrument was 0.869.   
Coping  
Coping strategies were measured using the Brief COPE questionnaire (Carver, 
1997; see Appendix IV). The Brief COPE questionnaire includes 28 questions classified 
into 14 components with two questions per component. Each question is measured using 
a 4-point scale (1 = I have not been doing this at all; 2 = I've been doing this a little bit; 3 
= I've been doing this a medium amount; and 4 = I have been doing this a lot). The 14 
components include: self-distraction, active coping, denial, substance use, use of 
emotional support, use of instrumental support, behavioral disengagement, venting, 
positive reframing, planning, humor, acceptance, religion, and self- blame. Based on 
evidence that these factors tend to be either generally adaptive or problematic, the 14 
components are further classified into two domains: adaptive coping or maladaptive 
coping (Carver, 1997). The adaptive coping domain contains eight components with 
possible scores of 0 to 48, and higher scores signify greater levels of adaptive coping. 
This domain includes the following components: active coping, planning, positive 
reframing, acceptance, humor, religion, using emotional support, and using instrumental 
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support. The maladaptive coping domain contains six components with possible scores of 
0 to 36, and higher scores signify greater levels of maladaptive coping. This domain 
includes the following components: self-distraction; denial; venting; substance use; 
behavioral disengagement; and self-blame. Cronbach’s alpha of the instrument was 
0.907.   
HIV Treatment Adherence  
HIV treatment adherence was measured using the Community Programs for 
Clinical Research on AIDS (CPCRA) Antiretroviral Medication Self-Report 
questionnaire (Form 646; Terry Beirn Community Programs for Clinical Research on 
AIDS, 2003; see Appendix II). This questionnaire uses a global 7-day recall and has slots 
for recording drug name, drug code, number of pills per dose, number of doses per day, 
and total number of pills per day (Appendix II). For each of the prescribed medications, 
the questionnaire records, whether the patients took “all,” “most,” “about half,” “very 
few,” or “none” of their pills during the preceding seven days. Adherence to each 
medication is calculated based on the percentages assigned to each of these responses, 
which include: “all” (100%); “most” (80%); “about half” (50%); “few” (20%); and 
“none” (0%). Total adherence is calculated as the mean of the total scores of all the 
individual medications and constitutes a continuous variable ranging from 0-100 percent. 
In this study, adherence was considered as a continuous variable.  
Data Analyses 
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures 
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.). 
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests 
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were used to describe the demographic characteristics. Independent samples t tests were 
used to compare perceived stigma and coping variables between those reporting higher 
versus lower levels of anxiety. Pearson correlations were used to find associations 
between anxiety levels, treatment adherence, the domains of perceived stigma (personal 
view and public view), and coping variables (adaptive coping and maladaptive coping). 
Structural equation modeling (SEM) was used to test the hypothesis whether the 
relationship between stigma and anxiety levels was mediated by the coping variable and 
whether there were any combined effects on treatment adherence. SEM accounts for 
multiple interactive relationships and variances and explores for directional associations 
between them leading to delineation of the mediators (Grimm & Yarnold, 2000; Kline, 
1998). For analysis, maximum-likelihood estimations were used for the AMOS modules. 
Statistical significance was set at p <0.05 for all the analyses.   
Results 
Demographic and socio-economic characteristics 
A total of 285 participants who reported taking medications were included in the 
secondary analyses and 42.3% were men (Table 1). The mean age of the cohort was 
36.43±8.62 (Mean±SD) years. About 59% of the participants had 6th grade or lesser 
levels education. About 60% reported that they were married and 59.6% were 
unemployed. The majority of the participants reported having primary care physicians 
(90.2%). There were significant differences in age and gender between those reporting 
low versus high levels of anxiety.   
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Stigma and anxiety levels 
There were no significant differences with respect to personal view, public view 
as well as total perceived stigma between those reporting low versus high levels of 
anxiety (Table 2). 
Coping scores and anxiety levels  
 Participants who reported higher levels of anxiety also reported significantly 
higher levels of total coping (p <.001; Table 3). Participants who reported higher levels of 
anxiety reported higher levels of maladaptive coping (p <.001). However, there were no 
significant differences in adaptive coping scores between participants reporting low 
versus high levels of anxiety. Participants who reported higher levels of anxiety also 
reported higher levels of planning, active coping, self-distraction, denial, substance use, 
behavioral disengagement, venting, and self-blame components of the questionnaire 
(Table 3).  
Treatment adherence and anxiety levels  
 There were significant differences in treatment adherence between participants 
reporting low versus high levels of anxiety. Participants who reported higher levels of 
anxiety reported significantly lower levels of treatment adherence (p = .011; Table 4).  
Relationship between anxiety, adherence, perceived stigma, and coping mechanisms 
Significant negative correlations were observed between anxiety levels and 
treatment adherence (r = -.141, p <0.05), and total coping scores (r = -.167, p <0.01; 
Table 5). Significant positive correlations were observed between anxiety levels and total 
perceived stigma (r = .123, p <0.05), perceived stigma-public view (r = .132, p <0.05) 
and maladaptive coping (r = .398, p <0.01). 
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Mediation analysis 
In the mediation analysis, coefficients were simultaneously estimated for all the 
variables that showed significant associations in bivariate analyses including perceived 
stigma, maladaptive coping, anxiety levels, and treatment adherence. There were 
significant associations between perceived sigma and maladaptive coping (Beta = .175, p 
= .003), perceived sigma and anxiety (Beta = .164, p = .005), maladaptive coping and 
anxiety (Beta = .229, p <.001), and anxiety and treatment adherence (Beta = -.140, p = 
.018). Figure 1 shows the path diagram for these variables. These observations suggest 
that maladaptive coping acted as a mediator on the relationship between stigma and 
anxiety levels which in turn had significant effects on treatment adherence.    
Discussion 
Many studies have shown that stigma was associated with poor mental and 
physical health outcomes, such as, anxiety and depression, increased risk seeking 
behaviors, and adverse disease progression parameters such as lower CD4 counts and 
higher viral load (Storholm et al., 2013; Earnshaw, Smith, Chaudoir, Amico, & 
Copenhaver, 2013; Holzemer et al., 2007). In the present study, there were significant 
associations between perceived stigma and anxiety levels. Results show that maladaptive 
coping strategies significantly mediated the associations between stigma and anxiety 
levels and in turn adversely affected treatment adherence. 
PLWH experience varying levels of anxiety disorders as reported in associated 
studies and range between 7% in some studies to as high as 82% in others (Kemppainen 
et al., 2003; Morrison et al., 2011). In a study done among 1,125 PLWH in the 
Southeastern United States, prevalence of anxiety disorders was as high as 39% (Pence, 
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Miller, Whetten, Eron & Gaynes, 2006). Similarly, a survey done among 85 PLWH in 
the South Africa showed that high levels of anxiety were reported by 52.9% of the 
participants (Kagee & Martin, 2010). Akin to these findings, this study reported high 
levels of anxiety in 47.2% of the participants. 
In this study, maladaptive coping adversely mediated the effects of stigma on 
anxiety levels. However, adaptive coping did not show any such effects. Similar findings 
were reported in another study, where disengagement coping (maladaptive coping) 
aggravated anxiety and depressive symptoms (Varni, Miller, McCuin, & Solomon, 2012). 
Higher levels of maladaptive coping and lower levels of adaptive coping were associated 
with higher levels of anxiety symptoms (Gonzalez, Solomon, Zvolensky, & Miller, 
2009). Contrasting these findings, a study done among Australian PLWH showed that 
adaptive coping was not associated with HIV-related stigma and anxiety (Pakenham & 
Rinaldis, 2001). The variety of these conflicting findings suggest that the relationship 
between stigma, anxiety and coping is very complex. Many different aspects of mental 
functioning are affected by the stressors associated with the HIV-related stigma. A 
number of different coping mechanisms are used to overcome these stressors (O’Donnell 
et al., 2013; Gore-Felton et al., 2013). Thus, the preponderance of either one of these 
factors (stressor versus coping) may affect the outcome variables such as anxiety levels. 
This explains why adaptive coping may be beneficial in lowering anxiety (Pakenham & 
Rinaldis, 2001), or may not show any association as observed in this study.  The same 
assumptions can be extrapolated to maladaptive coping, which showed adverse 
associations with anxiety in this study. Coping mechanisms are inherently different with 
regards to their impact on anxiety symptoms. Future interventions should therefore 
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consider not only the type of coping, but also their associations with different aspects of 
mental well-being. This could be achieved through improved assessment of perceived 
stigma and anxiety provoking factors.  
In this study, anxiety levels were adversely associated with treatment adherence. 
A number of studies have shown adverse associations between anxiety disorders and 
treatment adherence in several PLWH populations. For example, in a study done among 
85 female PLWH from New York City, many different components of anxiety were 
adversely associated with treatment adherence (Willie, Overstreet, Sullivan, Sikkema, & 
Hansen, 2015). In a multivariable analysis of 358 Italian PLWH, it was found that 
anxiety symptoms were significantly associated with treatment non-adherence 
(Ammassari et al., 2001). In a longitudinal study of 193 Swedish PLWH, Nilsson 
Schönnesson and colleagues (2007) reported that anxiety measured by the Brief 
Symptom Inventory, significantly predicted suboptimal treatment adherence. Similarly, 
in a Brazilian study among 293 PLWH, severe anxiety predicted treatment non-adherence 
after adjusting for education, employment, and substance use in the past 4 weeks 
(Campos, Guimarães, & Remien, 2010). These findings support the relevance of this 
study, where associations were found between stigma, coping mechanisms and anxiety 
levels, and their combined effects on treatment adherence.  
Irrespective of these findings, there were some limitations to this study. This 
study was cross-sectional and causal associations could not be determined. The study also 
lacked an HIV-negative comparison group and therefore there could be many 
confounders affecting these findings. The participants were privileged to have 
comprehensive health care services from the GHESKIO centers in Haiti. They could have 
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been significantly different from other PLWH in Haiti who had limited access to these 
services due to several reasons. This would compromise some of the external validity of 
the findings. The current study was a secondary analysis of baseline data collected for the 
parent study, leading to surrogate information biases. The data is self-reported, and 
participants were HIV positive alcohol users, which may have increased recall bias, and 
social desirability biases could have affected the findings of this study. 
Conclusion 
In summary, this study showed that the maladaptive coping strategies adversely 
mediated the relationship between stigma and anxiety symptoms. However, the beneficial 
mediating effect of adaptive coping on these factors was not evident. Furthermore, these 
adverse effects in turn potentiated the adverse effect of anxiety on treatment adherence. 
Thus, this study suggests that future intervention should aim at teaching PLWH to 
decrease their maladaptive coping strategies while dealing with HIV-related stigma. This 
could decrease their anxiety symptoms and improve their treatment adherence.  
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Table 4.1. Demographic characteristics of the participants 
Characteristics Anxiety p value Total 
(n=285, 
100%) 
Low 
(n=151, 
52.8%) 
High 
(n=134, 
47.2%) 
Age* 37.80±8.77 34.91±8.25 .005 36.43±8.62 
Gender   .008  
 Male 75 (49.7%) 45 (34.1%)  120 (42.3%) 
 Female 76 (50.3%) 89 (65.9%)  165 (57.7%) 
Education*   .869  
 6th grade or less 86 (59.3%) 77 (58.3%)  163 (58.8%) 
 Some high 
school or higher 
59 (40.7%) 55 (41.7%)  114 (41.2%) 
Marital status*   .202  
 Single or living 
as single 
66 (43.7%) 49 (36.3%)  115 (40.2%) 
 Married 85 (56.3%) 85 (63.7%)  170 (59.8%) 
Employment   .096  
 Full time job 1 (1.5%) 4 (4.4%)  5 (3.2%) 
 Seasonal job 22 (33.8%) 15 (16.5%)  37 (23.7%) 
 Unemployed 32 (49.2%) 61 (67.0%)  93 (59.6%) 
 Student 2 (3.1%) 2 (2.2%)  4 (2.6%) 
 Incapacitated 1 (1.5%) 0 (0%)  1 (0.6%) 
 Other 7 (10.8%) 9 (9.9%)  16 (10.3%) 
Income   .555  
 <$150 25 (29.8%) 10 (22.7%)  35 (27.3%) 
 $151-1,000 32 (38.1%) 16 (36.4%)  48 (37.5%) 
 >$1,000 27 (32.1%) 18 (40.9%)  45 (35.2%) 
Primary care   .200  
 Yes 133 (88.1%) 124 (92.6%)  257 (90.2%) 
 No 18 (11.9%) 10 (7.4%)  28 (9.8%) 
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact 
test 
*p<.05; **p<.01; ***p<.001 
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Table 4.2. Participants’ stigma by anxiety level  
Stigma Anxiety p value Total 
Low High 
Personal  54.33±7.94 54.88±8.40 .574 54.57±8.13 
Public 53.11±9.27 55.44±11.31 .060 54.15±10.30 
Total 107.09±16.14 110.32±17.50 .106 108.54±16.79 
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Table 4.3. Participants’ Brief COPE scores by anxiety level 
Brief COPE Anxiety p value Total 
Low High 
Adaptive coping 
Positive reframing 4.91±1.70 5.15±1.85 .262 5.02±1.77 
Use of instrumental support 5.12±1.82 5.08±1.96 .876 5.12±1.88 
Religion 5.90±1.79 6.00±1.54 .653 5.94±1.68 
Use of emotional support 4.89±1.67 4.90±1.85 .973 4.90±1.75 
Acceptance 5.00±1.57 5.11±1.71 .571 5.03±1.65 
Planning** 5.07±1.64 5.70±1.56 .001 5.36±1.62 
Active coping* 4.95±1.76 5.41±1.83 .034 5.16±1.80 
Humor 4.64±1.65 4.88±1.85 .250 4.77±1.76 
Total adaptive coping 40.52±8.95 42.26±9.40 .115 41.33±9.16 
 
Maladaptive coping 
Self-distraction** 4.59±1.64 5.29±1.79 .001 4.92±1.74 
Denial*** 4.54±1.71 5.51±1.74 .000 4.98±1.79 
Substance use*** 4.11±2.01 5.21±1.71 .000 4.65±2.15 
Behavioral disengagement*** 4.83±1.84 6.08±1.84 .000 5.42±1.95 
Venting* 4.85±1.73 5.36±1.77 .016 5.07±1.77 
Self-blame*** 4.90±1.92 5.92±1.82 .000 5.39±1.94 
Total maladaptive coping*** 27.84±7.55 33.41±7.46 .000 30.44±7.99 
     
Total coping*** 68.36±14.83 75.67±15.48 .000 71.78±15.50 
*p<.05; **p<.01; ***p<.001 
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Table 4.4. Participants’ treatment adherence by anxiety level  
Treatment 
adherence 
Anxiety p value 
Low High 
Adherence* 53.11±7.96 50.15±9.04 .011 
*p<.05
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Table 4.5. Correlation between anxiety, adherence, perceived stigma, and coping  
 1 2 3 4 5 6 7 8 
1. Anxiety ---        
2. Adherence -.141* ---       
3. Personal view .079 -.08 ---      
4. Public view .132* -.081 .562** ---     
5. Perceived stigma .123* -.093 .850** .912** ---    
6. Adaptive coping .048 -.025 -.324** -.271** -.333** ---   
7. Maladaptive coping .398** -.129* -.101 -0.051 -0.083 .632** ---  
8. Total coping -.167** .041 .182** .148* .184** -.586** -.542** --- 
*p<.05; **p<.01; ***p<.001 
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Figure 4.1. Path diagram to describe the interrelationship between HIV related stigma, 
maladaptive coping, anxiety, and HIV treatment adherence 
  
*p<.05; **p<.01; ***p<.001 
 
 
 
Maladaptive Coping 
.16** 
.18** 
-.14* 
Perceived stigma Adherence Anxiety 
.23*** 
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CHAPTER V: Relationships between Depression, Social Support and HIV-Related 
Stigma in Alcohol Using PLWH in Haiti 
Introduction  
  It has long been recognized that people living with HIV (PLWH) face significant 
psychosocial challenges that often result in complex mental health problems (Mellins & 
Malee, 2013; Petersen, et al., 2010; Tucker et al., 2004). Many studies on the health 
challenges faced by PLWH identify mental health problems as one of the most common 
comorbidities associated with HIV (Edmiston, Passmore, Smith, & Petoumenos, 2015; 
Kendall et al., 2014). Among these, depression is the most widespread (Choi, 2013), 
affecting PLWH at a rate nearly double that of the general population (Ciesla & Roberts, 
2001). Even the presence of depressive symptoms that do not meet the clinical criteria for 
depressive disorders result in impaired immunological responses and higher mortality 
rates (Ironson et al., 2005).  
One of the most significant risk factors for mental health problems (including 
depression) among PLWH includes HIV-related stigma. Stigma is a complex social 
process involving stereotyping, status loss, and discrimination (Mahajan et al., 2008). 
HIV-related stigma has been linked to the creation and maintenance of social inequalities, 
often along the lines of race, class, gender, and sexual orientation (Parker & Aggleton, 
2003). This is additionally complicated by stigmas related to drug useand homosexuality 
(Reidpath & Chan, 2005).  Several studies have shown that HIV-related stigma is more 
intense when compared to the stigmas associated with other illnesses such as herpes, 
cancer, tuberculosis etc. (Hatzenbuehler, Phelan & Link, 2013; Breet, Kagee & Seedat, 
2014; Crawford, 1996). Research has consistently shown that higher levels of stigma are 
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associated with lower levels of mental health in PLWH (Logie & Gadall, 2009) and HIV-
related stigma is said to be one of the greatest barriers towards providing adequate 
support and treatment to PLWH (Aggleton, 2002).  
 When faced with situations of acute/ongoing stress or the challenges of stigma 
and discrimination, individuals engage in coping processes that include behavioral as 
well as psychological adaptations aimed at overcoming the stressors or challenges 
(Taylor & Stanton, 2007). Among PLWH, stigma constitutes an important cause of 
stress, anxiety, panic and depression and PLWHs are exposed and forced to cope with it. 
The notion of “resilience resources” was constructed to identify the modifiable and 
strength-based moderators that have effects on the coping mechanisms adopted by 
PLWH (Earnshaw et al., 2015). The characteristics associated with resilience may be 
both individual (e.g. self-esteem, personality traits, coping style, spirituality, etc.) and 
social (e.g. supportive peer networks, relationship and support from family, friends etc.; 
Zhang et al., 2015). Research, particularly among PLWH, consistently highlights the 
instrumental role played by social support in both physical and mental health outcomes 
(Degroote, Vogelaers, & Vandijck, 2014). Studies show that social support is particularly 
effective in coping with depression, improving treatment adherence, and retention in 
treatment facilities (Yeji et al., 2014). PLWH with greater access to social support 
systems experience less stigma-related stress which may ultimately protect them from 
adverse HIV symptoms (Earnshaw, 2015). Evidently, more research is needed to better 
understand the relationships and interactions between these core aspects of HIV-related 
stigma, social support and depression.  
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The current study aims to understand the relationship between depression, social 
support and HIV-related stigma in a sample of HIV positive alcohol users living in 
resource limited settings such as Haiti. Studying the interrelationships between these 
variables will allow a greater understanding of the role played by each of these variables 
in influencing the health care outcomes in PLWH.  
Methods 
Study Design and Population 
The current study was a secondary analyses of data from the parent study entitled, 
“Intervening with Haitian HIV Positive Alcohol Users: An Environmental Psychosocial 
Framework.” The parent study was a randomized controlled trial that examined the 
effectiveness of the adapted CBSM-A intervention in simultaneously reducing risk 
behaviors, improving ART adherence and mood.  Participants were provided with 
information on HIV disease and its treatment, including currently available ART 
medications, the negative effects of substance use and high-risk sexual behavior on the 
immune system and health status, and the nature of stress and coping responses and 
resources. The skill building aspects of the parent study included: teaching anxiety 
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics; 
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing 
interpersonal conflict resolution skills and anger expression via anger management and 
assertion training; and providing a supportive group environment and increase utilization 
of social support networks. Data collection for the parent study occurred at the 
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections 
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed 
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to include a combination of problem-focused (e.g., active coping and planning) and 
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.  
  The parent study included participants who were: between18 and 60 years of age; 
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one 
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol 
consumption; were not cognitively impaired at the time of recruitment; and did not show 
symptoms of any major psychiatric disorder. The current study included subjects who 
participated in baseline assessments before the beginning of randomization and 
interventional follow-up visits. The institutional review board (IRB) at Florida 
International University approved this secondary analyses study in September, 2015.  
Measures 
Cognitive and Affective Symptoms of Depression  
The Centers for Epidemiological Studies Depression Scale (CES-D) is a 20-item 
questionnaire that assesses symptoms of depression over the past seven days (Radloff & 
Locke, 1986; see Appendix III). The somatic depression items in the CES-D overlap with 
HIV-related symptoms (Kalichman, Rompa, & Cage, 2000). The parent study 
administered only 15 questions which measured cognitive and affective symptoms of 
depression in order to limit confounding between somatic depression variables and HIV 
disease-related symptoms. Somatic depression questions such as restless sleep, anorexia, 
lack of energy, fatigue, and poor concentration were not included in the parent study. The 
resulting 15-item questionnaire measured mood related and attitudinal aspects of 
depression. Because the questionnaire was truncated to only 15 items, the original scale 
could not be applied to the parent study or current study and the scale was re-categorized 
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based on mean and standard deviation. Subjects were categorized as affectively depressed 
if they scored greater than one SD above the mean total scores on mood related and 
attitudinal aspects of depression. Cronbach’s alpha of the instrument was 0.749. 
Stigma of HIV/AIDS  
HIV/AIDS-related stigma was measured using the Perceived Stigma of 
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman, 
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale 
measures stigma in terms of two components – internalized stigma and externalized 
stigma. In order to measure these two parameters, the questionnaire includes two 
subsections – personal view and public view. The personal view subscale includes 
questions related to shame, guilt, blame, embarrassment, and poor self-worth due to HIV. 
The public view subscale includes questions related to participant’s perception about 
social stigma, for example, what the respondent thinks about other people's attitudes and 
beliefs towards his/her disease condition. The questions in the subscales are both 
positively and negatively phrased to increase the specificity of the responses. Both 
subscales have 24 questions measured by four-point Likert-type scale (1 = strongly agree 
to 4 = strongly disagree). The total score of each subscale ranges between 24 and 96 and 
higher scores represent higher levels of personal or public stigma. Cronbach’s alpha of 
the instrument was 0.867.   
Social Support 
Modified Medical Outcome Study Social Support Survey (mMOS-SSS) was used 
to assess the levels of social support received by the participants (Sherbourne & Stewart, 
1991; see Appendix VI). The mMOS-SSS questionnaire was developed to measure 
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medical outcome in the year 1991 and reported good internal validity (Cronbach’s alpha 
of the instrument was 0.787). This questionnaire includes an 8-item survey of perceived 
availability of social support and includes two subscales – emotional/informational social 
support and tangible/instrumental social support. The emotional/informational social 
support subscale measures empathy, love, trust and caring received by the participants. 
The tangible/instrumental social support subscale measures tangible benefits and services 
received by the participants. Each of the two subscales are measured in terms of a 5-point 
scale (1 = None of the time, 2 = A little of the time, 3 = Some of the time, 4 = Most of the 
time, and 5 = All of the time) and the total scores range from 8 to 40 and higher scores 
represents higher levels of social support.   
Data Analyses 
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures 
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.). 
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests 
were used to describe the demographic characteristics. Independent samples t tests were 
used to compare perceived stigma and social support variables between depressed and 
non-depressed participants. Pearson correlations were used to find associations between 
perceived stigma, depression, and social support variables. Multivariable linear 
regressions were used to estimate the predictors of depression with demographics, stigma 
and social support as independent variables. In the regressions analysis, crude models 
were initially used and subsequently adjusted for associated covariates. The covariates 
were also tested for significant associations with the outcome variable using bivariate 
analysis before being incorporated into the final model. To increase the validity of the 
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model, multicollinearity among covariates was tested prior to regression analyses. 
Adjusted models included non-missing values for all independent variables included in 
the models.  Structural equation modeling (SEM) was used to test the hypothesis whether 
the relationship between HIV-related stigma and depression was mediated by social 
support variables. SEM accounts for multiple interactive relationships and variances and 
explores for directional associations between them leading to delineation of the mediators 
(Grimm & Yarnold, 2000; Kline, 1998). Maximum-likelihood estimation methods were 
used for AMOS modules in the analyses. Statistical significance was set at p <0.05 for all 
the analyses.   
Results 
Demographic and socio-economic characteristics 
A total of 362 participants were included in the secondary analyses and 135 
(37.0%) were men (Table 1). The mean age of the sample was 35.72±8.50 (Mean±SD) 
years. Approximately 61% of the participants had a 6th grade or less education. About 
58% reported that they were married and about 59.7% were unemployed. The majority of 
the participants reported having primary care physicians (89.0%). Except for age, there 
were no significant differences in other socio-demographic variables between depressed 
and non-depressed participants.   
Stigma and depression 
Depressed participants reported higher levels of perceived stigma than non-
depressed participants (p = .034; Table 2). Similarly, depressed participants reported 
higher levels of perceived stigma-public view than non-depressed participants (p = .039). 
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However, there were no significant differences in perceived stigma-personal view 
between depressed and non-depressed participants. 
Social Support and depression 
  Depressed participants reported lower levels of both components of social support 
as well as total social support (emotional/informational social support, p = .002; 
tangible/instrumental social support, p = .000; and total social support, p = .000; Table 3).  
Relationships Between Perceived Stigma, Depression, and Social Support 
Significant positive correlations were observed between depression, and total 
social support (r = -0.199, p <0.01), emotional/informational social support (r = -0.162, p 
<0.01), and tangible/informational social support (r = -0.189, p <0.01). Significant 
negative correlations were observed between depression and perceived stigma-public 
view (r = 0.104, p <0.05; Table 4).  
Predictors of HIV treatment adherence 
In the adjusted multivariable linear regression model, being female (Beta = 3.076, 
p = .001), having lower tangible/informational social support (Beta = -0.309, p = .020), 
and having higher perceived stigma-public view (Beta = 1.877, p = .037) were 
significantly associated with higher levels of depression. The beta estimates and standard 
errors for each of the predictors are presented in Table 5. 
Mediation analysis 
In the mediation analysis, coefficients for all the variables including perceived 
stigma-personal view, perceived stigma-public view, emotional/informational social 
support, tangible/informational social support, and depression were estimated 
simultaneously. However, no significant associations were found between these variables 
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in our mediator analyses. Figure 1 shows the path diagram for the variables which 
showed significance in the regression analyses. In this model, there were significant 
associations between perceived stigma-public view and depression (Beta = 2.398, p = 
.021) and tangible/informational social support and depression (Beta = -0.412, p = .000). 
However, there were no associations between perceived stigma-public view and 
tangible/informational social support (Beta = 0.023, p = .531). These findings suggest 
that the effect of stigma on HIV treatment adherence is not mediated by social support.   
Discussion 
Similar to many other populations, Haitian PLWH are exposed to challenges such 
as limited social support, HIV-related stigma, and mental health problems (Vanable et al., 
2006). While these challenges are often addressed independently in many studies, our 
study is unique in integrating these complex variables. Our results show that perceived 
stigma-public view and tangible social support were significant predictors of depressive 
symptoms. Mediation analyses, however, showed that tangible social support did not act 
as a mediator between perceived stigma-public view and depressive symptoms. This 
could be due to the stronger effects of perceived stigma-public view on depressive 
symptoms. Social support could not alleviate the effect of stigma on depressive 
symptoms. 
About 45.6% of our participants reported depressive symptoms and was slightly 
greater than the prevalence (41.7%) reported in the Haitian general population 
(Wagenaar, 2012). Supporting the findings in our study, many other studies have reported 
higher levels of clinical depression in PLWH. For example, in a study done by Nakasujja 
et al. (2010) among PLWH in Uganda, about 53.9% reported higher levels of depressive 
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symptoms (CES-D scores ≥16). Similarly, in a study done among Kenyan PLWH, 
Monahan et al. (2009) found that about 34% of PLWH reported some form of depressive 
disorders.  
A significant number of our participants (47.8%) reported experiencing high 
levels of perceived stigma. A number of studies have reported that PLWH experience 
significant levels of perceived stigma. For example, in a study done by Kalichman et al. 
(2005) among 2,306 South African PLWH, 27% believed that they were dirty, 38% 
reported being ashamed of their condition, and 41% felt guilty of having acquired HIV. 
Similarly, in a Ugandan study, high levels of stigma were reported by PLWH and the 
levels of stigma increased over time (Chan et al., 2015). 
Our study found that being female, having higher perceived stigma-public view 
and lower tangible social support were associated with higher levels of depression. 
Consistent with other studies, PLWH in our study who perceived being more stigmatized 
reported higher levels depressive symptoms (Berger et al., 2001; Lee et al., 2002). The 
strong associations between perceived stigma-public view and depressive symptoms 
highlight the prominent role played by self-perceived stigma in aggravating mental health 
problems. Depression is characterized by a negative pattern of thinking, in which 
unfortunate events are associated with personal faults (for example, something bad 
happened to me because of my own mistake), and positive events are believed to be 
governed by extracorporeal forces (for example, something good happened to me because 
of sheer luck). Internalized stigma reinforces depressive feelings because it characterizes 
similar conceptualizations wherein unfortunate events are associated with personal faults 
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(for example, one deserves to be the target of prejudice because one possesses the 
discriminatory negative attribute; Peterson, 1988; Peterson, Seligman, & Vaillant, 1988).  
In our study, tangible/instrumental social support significantly and negatively 
predicted depressive symptoms. Tangible/instrumental social support can range from 
making a meal for someone to driving that person to the doctor’s office. In some 
situations, individuals need material goods or tangible actions to help them overcome 
challenging circumstances (Sherbourne & Stewart, 1991). Many other studies have 
highlighted the importance of tangible social support in chronic disease states. For 
example, in a randomized controlled trial done in Uganda, participants who received 
tangible/instrumental social support in terms of treatment support personnel had 4 times 
higher odds of achieving optimum HIV treatment adherence when compared to those 
without support personnel (Kunutsor, 2011). Similarly, many studies have documented a 
direct relationship between tangible/instrumental social support and increased adherence 
to ART (Gonzalez et al., 2004, Ulett et al., 2009 and Vyavaharkar et al., 2010). However, 
similar studies associating the effects of tangible/instrumental social support in 
alleviating the effects of depressive symptoms in PLWH are sparse. Nevertheless, many 
studies exist about the beneficial effects of total social support (encompassing 
emotional/informational and tangible/instrumental social support) in minimizing 
psychological stressors in PLWH. For example, social support is particularly important in 
women because they rely on social interactions and acquaintances for reliving their 
stressors (Hurdle, 2001). Many studies also report inverse associations between total 
social support and depression in PLWH (Catz, Gore-Felton, & McClure, 2002; 
McDowell & Serovich, 2007). However, in our study, though there were inverse and 
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beneficial associations between tangible/instrumental social support and depression, 
similar findings were not evident for emotional/informational arm of the social support 
variable. 
In the current study, men relied less on social support and reported lower levels of 
depressive symptoms when compared to women. This is consistent with abundant 
literature on gender differences in the prevalence of depression as well as the coping 
mechanisms. Women generally tend to have greater depression levels and rely more on 
social support for coping with their stressors. For example, in a review about gender 
differences in depression, Nolen-Hoeksema (2001) reported that women in general were 
twice as likely to suffer from depression when compared to men, irrespective of 
nationalities, cultural affiliations and ethnicities. In a Rwandan study on female PLWH, 
women with HIV reported extremely high prevalence (81%) of depressive disorders 
(Cohen, 2011). Nolen-Hoeksema et al. (1999) proposed the Response Style Theory 
(RST), wherein women were more likely to ruminate in response to dysphoric or 
depressive moods, reinforcing the negative spiral of acute and chronic depressive states. 
Men on the contrary adopt distraction techniques to cope with depressed or dysphoric 
states thereby overcoming it. These inherent gender differences in coping mechanisms 
has been proposed as one of the reasons for greater prevalence of depressive disorders in 
females. This could also be the reason why social support mechanisms are more relied 
upon by women as a means of distraction to overcome their depressed states. However, 
studies have also suggested that men resort to harmful distractions such as substance use, 
risky sexual behaviors and risk seeking behaviors to overcome their dysphoric states 
(McBride & Bagby, 2006). 
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Irrespective of the significant findings in the study, there are some limitations. 
The parent study enrolled a consecutive convenience sample of PLWH attending the 
GHESKIO centers in Haiti. This sample of frequent health care users could be 
significantly different from the general population of PLWH in Haiti. As the parent study 
did not employ a random sampling technique for selecting participants from the total 
population of PLWH in Haiti, the findings in the current study are not generalizable, 
thereby limiting the external validity. The current study constituted a secondary analyses 
of variables collected for the parent study. This could be responsible for some surrogate 
information biases in the current study. This study was a cross-sectional analyses of 
baseline data collected for the parent study. Because of the cross-sectional nature of the 
study, only associations could be derived and causal relationships could not be 
established. Furthermore, this study did not have an HIV-negative comparison group to 
eliminate the effects of confounders influencing the relationship between independent 
and outcome variables in the study.  
Conclusion 
Our results suggest that comprehensive care for PLWH in Haiti should consider 
the relationship between intrapersonal (e.g. depression, stigma) and interpersonal (i.e., 
social support) variables. Such efforts should also encompass gender-based adaptations to 
account for the higher prevalence of depression in female PLWH. Our findings also 
suggest that improving social support and reducing stigma could be very useful in 
decreasing the prevalence as well as the adverse effects of depressive disorders in PLWH. 
Such multilevel efforts incorporating many interrelated constructs could bring significant 
changes in health status and general well-being of Haitian PLWH.  
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Table 5.1. Demographic characteristics of the participants  
Characteristics Mood related and attitudinal 
depression 
p 
value 
Total 
(n=362, 
100%) Non-depressed 
(n=197, 
54.4%) 
Depressed 
(n=165, 
45.6%) 
Age 35.92±8.36 35.48±8.68 .629 35.72±8.50 
Gender**   .008  
 Male 85 (43.1%) 49 (29.7%)  135 
(37.0%) 
 Female 112 (56.9%) 116 (70.3%)  228 
(63.0%) 
Education   .074  
 6th grade or less 112 (56.9%) 109 (66.1%)  221 
(61.0%) 
 Some high school or 
higher 
85 (43.1%) 56 (33.9%)  141 
(39.0%) 
Marital status   .221  
 Single or living as 
single 
77 (39.1%) 75 (45.5%)  152 
(42.0%) 
 Married 120 (60.9%) 90 (54.5%)  210 
(58.0%) 
Employment   .110  
 Full time job 3 (3.1%) 2 (1.9%)  5 (2.5%) 
 Seasonal job 24 (24.5%) 22 (21.4%)  46 (22.9%) 
 Unemployed 52 (53.1%) 68 (66.0%)  120 
(59.7%) 
 Student 5 (5.1%) 0 (0%)  5 (2.5%) 
 Incapacitated 0 (0%) 1 (1.0%)  1 (0.5%) 
 Other 14 (14.3%) 10 (9.7%)  24 (11.9%) 
Income   .807  
 <$150 27 (28.1%) 17 (27.4%)  44 (27.8%) 
 $151-1,000 38 (39.6%) 22 (35.5%)  60 (38.0%) 
 >$1,000 31 (32.3%) 23 (37.1%)  54 (34.2%) 
Primary care   .452  
 Yes 173 (87.8%) 149 (90.3%)  322 
(89.0%) 
 No 24 (12.2%) 16 (9.7%)  40 (11.0%) 
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact 
test 
*p<.05; **p<.01; ***p<.001
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Table 5.2. Comparison of perceived stigma by mood related and attitudinal depression 
among participants 
Perceived stigma Mood related and attitudinal 
depression 
p value Total 
Non-depressed Depressed 
Personal view 53.75±7.89 55.17±8.25 .095 54.39±8.07 
Public view* 52.76±9.97 55.02±10.77 .039 53.79±10.38 
Total* 106.51±15.80 110.19±17.16 .034 108.18±16.51 
*p<.05; **p<.01; ***p<.001
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Table 5.3. Comparison of social support by mood related and attitudinal depression 
among participants 
Social support Mood related and attitudinal 
depression 
p value Total 
Non-depressed Depressed 
Emotional/informational 
support** 
12.88±3.80 
 
11.52±4.48 
 
.002 12.26±4.17 
 
Tangible support*** 11.61±3.51 10.01±3.83 .000 10.88±3.74 
Total*** 24.50±6.22 21.53±7.42 .000 23.14±6.94 
*p<.05; **p<.01; ***p<.001
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Table 5.4. Correlations among perceived stigma, depression, social support and demographic characteristics  
 1 2 3 4 5 6 7 
1. Depression ---       
2. Perceived stigma .085 ---      
3. Personal view .039 .862** ---     
4. Public view .104* .919** .594** ---    
5. Social support -.199** -.077 -.058 -.077 ---   
6. Emotional/ 
informational 
support 
-.162** -.103  -.071  -.108*  .891**  ---   
7. Tangible support -.189** -.028 -.028 -.022 .862** .537** --- 
*p<.05; **p<.01; ***p<.001
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Table 5.5. Multivariable linear regression predicting depression 
Independent variables Estimate Standard 
error 
Beta p value 
Age .053  .051 .055 .302 
Sex** 3.076 .907 .182 .001 
Education -1.351 .878 -.081 .125 
Marital status -.394  .856 -.024 .645 
Primary care physician -.390 1.323 -.015 .769 
Emotional/informational 
support  
-.124 .118 -.063 .295 
Tangible support* -.309  .132 -.142 .020 
Personal view  .191  .884 .012 .829 
Public view* 1.877 .898 .115 .037 
*p<.05; **p<.01; ***p<.001  
Adjusted R-squared value = .26          
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Figure 5.1. Path diagram to describe the interrelationship between HIV related stigma, 
social support and depression 
  
*p<.05; **p<.01; ***p<.001
Tangible support 
Depression 
2.398**
cv 
.023 -.412*** 
Perceived stigma – public view 
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CHAPTER VI: Summary, Limitations and Future Extensions 
Summary of the Study 
The present study was a secondary analyses of baseline data collected from a 
convenience sample of 389 alcohol using PLWH who attended the GHESKIO Centers in 
Port-au-Prince, Haiti. The parent study was a randomized controlled trial that evaluated 
the effectiveness of an adapted CBSM-A intervention. This secondary analyses examined 
the effects of HIV-related stigma on treatment adherence and how factors like depression, 
social support, coping, and anxiety mediated this relationship.   
The mean age of the cohort was 35.72±8.50 (Mean±SD) years. About 37.0% were 
male participants. About 59% reported a 6th grade or less level of education. More than 
half of them were unemployed (59.2%). Approximately 27% of the participants reported 
income less than $150 per annum. These characteristics represent the general levels of 
poverty prevalent in Haiti (Farmer, 2006). Albeit, the majority of the participants 
reported having primary care physicians (91.2%) strikingly higher than the health care 
characteristics of PLWH in Haiti (Peck et al., 2003). The mean treatment adherence was 
93.1%, and this included 100% adherence reported by 71.9% of the cohort. About 50.2% 
reported high levels of total perceived stigma, 47.2% reported high levels of perceived 
stigma-public view, and 48.7% reported high levels of perceived stigma-personal view. 
About 58.1% received high levels of tangible/informational social support and 53.9% 
received high levels of emotional/informational social support. Slightly greater than half 
of all participants (51.1%) reported high levels of total coping, 50.2% reported high 
levels of adaptive coping, and 51.6% reported high levels of maladaptive coping. About 
 139 
 
45.6% reported clinical depression and 47.2% reported clinically significant symptoms 
for the state anxiety.   
Significant positive correlations were observed between treatment adherence and 
satisfaction of quality of care scores (p <0.01). Many studies have documented that 
treatment adherence is improved by increasing the quality of health care through higher 
levels of comprehensiveness, competence, continuity of care, consistency, and 
compassion demonstrated by the health care personnel during clinical encounters 
(Bristow, Chang, Ziogas & Anton-Culver, 2013; Ratanawongsa et al., 2013; Williams & 
Friedland, 1997). Higher levels of anxiety were associated with higher levels of total 
perceived stigma (p <0.05), perceived stigma-public view (p <0.05), and maladaptive 
coping (p <0.01). Similar associations were observed in other studies where higher levels 
of anxiety and other psychiatric disorders were associated with higher levels of stigma 
and maladaptive coping mechanisms (Alonzo & Reynolds, 1995; Gonzalez, Solomon, 
Zvolensky & Miller, 2009; Varni, Miller, McCuin & Solomon, 2012). 
Significant negative correlations were observed between treatment adherence and 
total perceived stigma (p <0.05), maladaptive coping (p <0.05), and anxiety levels (p 
<0.05). Stigma, maladaptive coping, and anxiety levels have adversely affected treatment 
adherence in similar other studies (Katz et al., 2013). In the current study, we found that 
higher levels of perceived stigma-public view (p <0.05), lower levels of total social 
support (p <0.01), emotional/informational social support (p <0.01) and 
tangible/informational social support (p <0.01) were associated with higher levels of 
depression. In the adjusted multivariable linear regression model predicting depression, 
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being female (p = .001), having lower tangible/informational social support (p = .020), 
and having higher perceived stigma-public view (p = .037) were significantly associated 
with higher levels of depression. In the adjusted multivariable linear regression model for 
predicting HIV treatment adherence, perceived stigma (p = .031), showed significant 
negative associations with treatment adherence, whereas, satisfaction of quality of care 
scores (Beta = .032, p = .041) showed positive association with treatment adherence. A 
number of studies have demonstrated the determinants of depression which include 
stigma, female gender, and lack of social support in several other populations (Simbayi et 
al., 2007; Li, Lee, Thammawijaya, Jiraphongsa & Rotheram-Borus, 2009). In addition, 
studies have also documented that these factors adversely affected treatment adherence 
(Rintamaki, Davis, Skripkauskas, Bennett & Wolf, 2006; Uthman, Magidson, Safren & 
Nachega, 2014; Horvath et al., 2013).  
In the mediation analysis looking for the mediator effects of maladaptive coping 
on the relationship between stigma and anxiety, there were significant associations 
between perceived sigma and coping (Beta = .175, p = .003), perceived sigma and 
anxiety (Beta = .164, p = .005), coping and anxiety (Beta = .229, p <.001), and anxiety 
and treatment adherence (Beta = -.140, p = .018). These observations suggest that 
maladaptive coping acted as a mediator between stigma and anxiety levels which in turn 
had significant effects on treatment adherence. However, in the mediation analysis 
looking for the mediator effects of maladaptive coping on the relationship between HIV-
related stigma and treatment adherence, there were no significant mediator effects. 
Similarly, in the mediation analysis looking for the mediator effects of social support on 
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the effects of stigma on depression, there were no significant mediator effects. The lack 
of mediating effects could be due to the limited variability associated with only using 
baseline data as well as participants using the GHESKIO Centers in Haiti. Further 
longitudinal studies could unfold these associations.  
Strengths and Limitations 
The greatest strength of our study is in filling the gap in literature on the 
associations between stigma, depression, anxiety, coping, social support and treatment 
adherence among PLWH in Haiti. For the first time, we identified that maladaptive 
coping mediated the relationship between stigma and anxiety in Haitian PLWH 
population. A number of associations were found in the study between outcome variables 
such as treatment adherence, depression and anxiety opening up newer hypothesis for 
further long term experimental studies in this population. The current study will serve as 
a link joining the findings in other studies applied to the Haitian PLWH population.  
Irrespective of many salient findings, this study had certain limitations. The 
parent study recruited a convenience sample of HIV positive participants attending the 
GHESKIO Centers in Haiti. The parent study was a randomized controlled trial and had 
an experimental and control arm thereby eliminating this selection bias. However, the 
current study only cross-sectionally analyzed baseline data of the parent study and did not 
have a control group. This group of participants attended the GHESKIO Centers and 
complied with the rules and protocols of the parent study and did not absolutely represent 
the entire population of disadvantaged and resource poor HIV positive participants in 
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Haiti. Thus, the results of the current study cannot be extrapolated to the entire 
population, thereby compromising some of its external validity. 
This study included only participants reporting ART and did not include ART 
naive participants. Thus, the results observed in this dissertation cannot be generalized to 
the entire population of HIV positive individuals in Haiti, because only 53% of all HIV 
positive patients in Haiti receive ART (UNICEF, 2013). Longitudinal studies and clinical 
trials can establish causal relationships, whereas the current dissertation was a cross-
sectional study and enabled an examination of only existing associations at a point in 
time and causal associations could not be determined.  
Data used for the current study were collected for the specific aims of the parent 
study and would not have absolutely complied with the specific aims of the current study. 
This could be responsible for some surrogate information biases in the current study. The 
variables that were collected in the parent study were secondarily analyzed and adjusted 
in the current study. There could be a number of other unaccounted factors affecting the 
outcome variables in the current study. However, the current study is a secondary 
analysis and the confounders cannot be estimated, thus limiting the results of the study.  
The majority of the questionnaires including the CPCRA Antiretroviral 
Medication Self-Report questionnaire, Perceived Stigma of HIV/AIDS, STAI, Brief 
COPE, mMOS-SSS, and CES-D were self-reported questionnaires and therefore 
susceptible to memory and recall biases. These questionnaires are also susceptible to 
social desirability bias wherein the participants respond to the questions in a favorable 
and socially desirable ways. This bias interferes with the interpretation of average 
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tendencies and individual differences. Such biases could decrease the internal validity of 
the study. 
Future Extensions        
PLWH often have complicated past histories including depression, anxiety, 
stigmatic experiences, and inadequate social support (Vyavaharkar et al, 2010; Charles et 
al., 2012). These factors can adversely affect treatment adherence, risk behaviors, and 
quality of life. Outcomes from this study may be informative in developing successful 
strategies for stigma, coping, anxiety and depression and planning effective interventions 
for improving treatment adherence in HIV positive populations. The findings in this 
study may significantly contribute towards fueling future research on the same topic. This 
cross-sectional analyses may serve as a basis for future large scale studies on the 
association between stigma and treatment adherence. Several other factors that could not 
be measured in this study can be progressively determined, measured and analyzed in 
future large scale longitudinal and randomized trials. Successive large scale research on 
this topic can help in stimulating empowerment programs and legislation, thereby 
empowering HIV-positive community against stigma and discrimination. Healthcare 
providers should be made aware that anxiety, depression, coping and stigma could act as 
barriers and should be addressed in any standard HIV care services. This can alleviate the 
already failing health conditions of these patients due to impoverishment and natural 
disasters and contribute to significant immune recuperation and general well-being. 
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Appendix I 
 
Perceived Stigma of HIV/AIDS 
 
Perceived Stigma of HIV/AIDS: Personal View 
 
Let's go over the instructions together. 
[READ INSTRUCTIONS TOGETHER.] 
 
Let's do the first item together. 
[GO OVER THE FIRST ITEM.] 
 
If you have any questions, please feel free to ask me. 
 
Here are some statements that people with HIV have made about themselves. For each 
statement, circle the answer that comes closest to the way you feel about yourself. 
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1. When people know I have HIV I feel 
uncomfortable around them. 
1 2 3 4 
2. I feel ashamed that I have HIV. 1 2 3 4 
3. Because I have HIV, I should not take care of other 
people's children. 
1 2 3 4 
4. I have been brave in handling my HIV. 1 2 3 4 
5. I must have done something to deserve getting 
HIV. 
1 2 3 4 
6. I should not share dishes or glasses just in case 
someone might catch HIV from me.  
1 2 3 4 
7. If I applied for a job, and someone else also applied 
who did not have HIV, the employer should hire the 
other person. 
1 2 3 4 
8. Although I have HIV, I am a person who deserves 
as much respect as anyone else. 
1 2 3 4 
9. I feel that it was my fault that I got HIV. 1 2 3 4 
10. People are right to be afraid of me because I have 
HIV. 
1 2 3 4 
11. Because of my HIV, I feel I am less attractive to 
those who might want to date me. 
1 2 3 4 
12. I have a lot to teach people about life through 
having HIV. 
1 2 3 4 
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13. I am embarrassed about having HIV. 1 2 3 4 
14. I feel it is completely safe for me to care for other 
people’s children even though I have HIV. 
1 2 3 4 
15. I deserve a lot of credit for how well I have coped 
with HIV.  
1 2 3 4 
16. I feel guilty about having HIV. 1 2 3 4 
17. I agree with mothers who do not want their children 
to play with my children because of my HIV. 
    
18. I understand why people would reject my 
friendship because I have HIV.  
1 2 3 4 
19. I think I am a person of good moral character. 1 2 3 4 
20. I feel ashamed about the way I got HIV. 1 2 3 4 
21. Because of my HIV, I should not hold a new infant. 1 2 3 4 
22. My neighbors would be right to be upset if they 
learned I had HIV. 
1 2 3 4 
23. I think less of myself because I have HIV. 1 2 3 4 
24. I think that my getting HIV was just a matter of bad 
luck. 
1 2 3 4 
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Perceived Stigma of HIV/AIDS: Public View 
 
Let's go over the instructions together. 
[READ INSTRUCTIONS TOGETHER.] 
 
Let's do the first item together. 
[GO OVER THE FIRST ITEM.] 
If you have any questions, please feel free to ask me. 
 
The general public has a wide range of beliefs about people who have AIDS or HIV.   
Here is a list of some examples of these beliefs and attitudes.  For each statement, circle 
the answer that best describes what you think other people's beliefs and attitudes are 
about HIV. 
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1. Most people believe that if you have HIV, you must 
have done something to deserve it. 
1 2 3 4 
2. Most people are afraid to be around a person with 
HIV. 
1 2 3 4 
3. Most people are uncomfortable around people who 
have HIV. 
1 2 3 4 
4. Most people think less of a person who has HIV.
  
1 2 3 4 
5. Most people think that people with HIV are of good 
moral character. 
1 2 3 4 
6. Most people think that someone with HIV should 
not take care of  
7. other people's children. 
1 2 3 4 
8. Most people think that people with HIV deserve 
respect as much as anyone else. 
1 2 3 4 
9. Most people feel that if you have HIV, it is your 
own fault. 
1 2 3 4 
10. Most mothers would allow their children to play 
with a child whose mother has HIV.  
1 2 3 4 
11. Most people would reject the friendship of a person 
with HIV. 
1 2 3 4 
12. Most people think that if you have HIV you are not 
as good as everyone else. 
1 2 3 4 
13. Most people think you should be embarrassed about 
having HIV. 
1 2 3 4 
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14. Most people would not share dishes or glasses with 
someone who has HIV because they are afraid they 
will catch it. 
1 2 3 4 
15. Most people would be upset if someone with HIV 
moved in next door. 
1 2 3 4 
16. Most people believe that having HIV is something 
to be ashamed about. 
1 2 3 4 
17. Most people think that people with HIV should be 
admired for their bravery in the face of the illness.
  
1 2 3 4 
18. Most people think that people with HIV should feel 
guilty about it. 
    
19. Most mothers would not want someone with HIV to 
hold their new infant. 
1 2 3 4 
20. Most people feel less attracted (as a date) to 
someone with HIV. 
1 2 3 4 
21. Most people believe that people with HIV deserve a 
lot of credit for how well they cope with the 
disease. 
1 2 3 4 
22. Most people feel that how you get HIV is 
something to be ashamed about. 
1 2 3 4 
23. Most people think that getting HIV is just a matter 
of bad luck. 
1 2 3 4 
24. Most employers would hire someone with HIV to 
work for them. 
1 2 3 4 
25. Most people think that people with HIV can teach 
us a lot about life. 
1 2 3 4 
 
The Perceived Stigma of HIV/AIDS (Bauman, Camacho, Westbrook, & Forbes-
Jones, 1997; Bauman, Silver, & Camacho, 2000; Westbrook & Bauman, 1996) scale is 
based on the conceptualization of stigma as having internalized as well as externalized 
components.  The authors, Westbrook and Bauman, hypothesize that stigma will cause 
greater distress and lower self-esteem when the stigmatizing beliefs of others, the 
externalized dimension, is internalized.  The instrument has two scales.  The Perceived 
Stigma of HIV/AIDS: Personal View subscale is a 24-item instrument including stigma 
items that reflect shame, guilt, blame, embarrassment, and poor self-worth because of 
HIV.  The Perceived Stigma of HIV/AIDS: Public View subscale contains 24 items 
designed to obtain the participant’s perception of social stigma, i.e., what the respondent 
thinks other people's attitudes and beliefs are about HIV. 
The items are phrased positively and negatively, and respondents indicate level of 
agreement on a four-point Likert-type scale (1=Strongly agree to 4=Strongly disagree).  
On the Personal View scale, recode items 1-3, 5-7, 9-11, 13, 16-18, and 20-24 as (4=1) 
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(3=2) (2=3) (1=4) and on the Public View subscale reverse items 1-4, 6, 8, 10-15, 17-19, 
21-22.  Sum the item values to create the subscale score.  You may use mean substitution 
for missing items.  Higher subscale scores indicate a higher level of personal or public 
stigma.   
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Appendix II 
Community Programs for Clinical Research on AIDS (CPCRA) Adherence Self-
Report Questionnaire  
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Appendix III 
 
Center for Epidemiological Studies - Depression (CES-D) 
Affective Depression (15-item) 
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 d
ay
s)
 
1. How often did you feel bothered by 
things that don't usually bother you? 
0 1 2 3 
2. How often did you feel that you could 
not shake off the blues even with help 
from family or friends? 
0 1 2 3 
3. How often did you feel that you were 
just as good as other people? 
0 1 2 3 
4. How often did you feel depressed? 0 1 2 3 
5. How often did you feel hopeful about 
the future? 
0 1 2 3 
6. How often did you feel that your life 
had been a failure? 
0 1 2 3 
7. How often did you feel fearful? 0 1 2 3 
8. How often did you feel happy? 0 1 2 3 
9. How often did you talk less than usual? 0 1 2 3 
10. How often did you feel lonely? 0 1 2 3 
11. How often did you feel that people 
were unfriendly? 
0 1 2 3 
12. How often did you enjoy life? 0 1 2 3 
13. How often did you have crying spells? 0 1 2 3 
14. How often did you feel sad? 0 1 2 3 
15. How often did you feel that people 
disliked you? 
0 1 2 3 
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Appendix IV 
 
Brief COPE 
  
 I haven't 
been 
doing 
this at all 
I've 
been 
doing 
this a 
little bit 
I've been 
doing this 
a medium 
amount 
I've 
been 
doing 
this a 
lot 
1. I've been turning to work or other 
activities to take my mind off things.  
1 2 3 4 
2. I've been concentrating my efforts on 
doing something about the situation 
I'm in.  
1 2 3 4 
3. I've been saying to myself "this isn't 
real.".  
1 2 3 4 
4. I've been using alcohol or other drugs 
to make myself feel better.  
1 2 3 4 
5. I've been getting emotional support 
from others.  
1 2 3 4 
6. I've been giving up trying to deal 
with it.  
1 2 3 4 
7. I've been taking action to try to make 
the situation better.  
1 2 3 4 
8. I've been refusing to believe that it 
has happened.  
1 2 3 4 
9. I've been saying things to let my 
unpleasant feelings escape.  
1 2 3 4 
10. I’ve been getting help and advice 
from other people.  
1 2 3 4 
11. I've been using alcohol or other drugs 
to help me get through it.  
1 2 3 4 
12. I've been trying to see it in a different 
light, to make it seem more positive.  
1 2 3 4 
13. I’ve been criticizing myself.  1 2 3 4 
14. I've been trying to come up with a 
strategy about what to do.  
1 2 3 4 
15. I've been getting comfort and 
understanding from someone.  
1 2 3 4 
16. I've been giving up the attempt to 
cope.  
1 2 3 4 
17. I've been looking for something good 
in what is happening.  
1 2 3 4 
18. I've been making jokes about it.  1 2 3 4 
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19. I've been doing something to think 
about it less, such as going to 
movies, watching TV, reading, 
daydreaming, sleeping, or shopping.  
1 2 3 4 
20. I've been accepting the reality of the 
fact that it has happened.  
1 2 3 4 
21. I've been expressing my negative 
feelings.  
1 2 3 4 
22. I've been trying to find comfort in my 
religion or spiritual beliefs.  
1 2 3 4 
23. I’ve been trying to get advice or help 
from other people about what to do.  
1 2 3 4 
24. I've been learning to live with it.  1 2 3 4 
25. I've been thinking hard about what 
steps to take.  
1 2 3 4 
26. I’ve been blaming myself for things 
that happened.  
1 2 3 4 
27. I've been praying or meditating.  1 2 3 4 
28. I've been making fun of the situation. 1 2 3 4 
 
Scales are computed as follows (with no reversals of coding): 
1. Self-distraction, items 1 and 19 (Maladaptive Coping) 
2. Active coping, items 2 and 7 (Adaptive Coping) 
3. Denial, items 3 and 8 (Maladaptive Coping) 
4. Substance use, items 4 and 11 (Maladaptive Coping) 
5. Use of emotional support, items 5 and 15 (Adaptive Coping) 
6. Use of instrumental support, items 10 and 23 (Adaptive Coping) 
7. Behavioral disengagement, items 6 and 16 (Maladaptive Coping) 
8. Venting, items 9 and 21 (Maladaptive Coping) 
9. Positive reframing, items 12 and 17 (Adaptive Coping) 
10. Planning, items 14 and 25 (Adaptive Coping) 
11. Humor, items 18 and 28 (Adaptive Coping) 
12. Acceptance, items 20 and 24 (Adaptive Coping) 
13. Religion, items 22 and 27 (Adaptive Coping) 
14. Self-blame, items 13 and 26 (Maladaptive Coping) 
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Appendix V  
 
State-Trait Anxiety Inventory (STAI) Form Y-1 
 
Please provide the following information: 
Name: ___________________________________    Date: ___________    S: 
___________ 
Age: _______________     Gender (Circle):   M   F            T: _______ 
 
DIRECTIONS: A number of statements which people have used to describe themselves 
are given below. Read each statement and then circle the appropriate number to the right 
of the statement to indicate how you feel right now, that is, at this moment. There are no 
right or wrong answers. Do not spend too much time on any one statement but give the 
answer which seems to describe your present feelings best. 
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1. I feel calm 1 2 3 4 
2. I feel secure 1 2 3 4 
3. I am tense 1 2 3 4 
4. I feel strained 1 2 3 4 
5. I feel at ease 1 2 3 4 
6. I feel upset 1 2 3 4 
7. I am presently worrying over possible misfortunes 1 2 3 4 
8. I feel satisfied 1 2 3 4 
9. I feel frightened 1 2 3 4 
10. I feel comfortable 1 2 3 4 
11. I feel self-confident 1 2 3 4 
12. I feel nervous 1 2 3 4 
13. I am jittery 1 2 3 4 
14. I feel indecisive 1 2 3 4 
15. I am relaxed 1 2 3 4 
16. I feel content 1 2 3 4 
17. I am worried 1 2 3 4 
18. I feel confused 1 2 3 4 
19. I feel steady 1 2 3 4 
20. I feel pleasant 1 2 3 4 
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State-Trait Anxiety Inventory for Adults Scoring Key (Form Y-1) 
Developed by Charles D. Spielberger in collaboration with R.L. Gorsuch, R. Lushene, 
P.R. Vagg, and G.A. Jacobs 
 
To use this stencil, fold this sheet in half and line up with the appropriate test side, Form 
Y-1. Simply total the scoring weights shown on the stencil for each response category. 
For example, for question # 1, if the respondent marked 3, then the weight would be 2. 
Refer to the manual for appropriate normative data 
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1. 4 3 2 1 
2. 4 3 2 1 
3. 1 2 3 4 
4. 1 2 3 4 
5. 4 3 2 1 
6. 1 2 3 4 
7. 1 2 3 4 
8. 4 3 2 1 
9. 1 2 3 4 
10. 4 3 2 1 
11. 4 3 2 1 
12. 1 2 3 4 
13. 1 2 3 4 
14. 1 2 3 4 
15. 4 3 2 1 
16. 4 3 2 1 
17. 1 2 3 4 
18. 1 2 3 4 
19. 4 3 2 1 
20. 4 3 2 1 
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Appendix VI 
 
Modified Medical Outcomes Study Social Support Survey (mMOS-SSS) 
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Emotional/Informational Support 
1. Would someone be available to talk to you if 
you were upset, nervous or depressed? 
1 2 3 4 5 
2. Is there someone you could contact if you 
wanted to talk about an important personal 
problem you were having? 
1 2 3 4 5 
3. Would the people in your personal life give 
you information, suggestions, or guidance if 
you needed it? 
1 2 3 4 5 
4. Is there someone you could turn to if you 
needed advice to help make a decision? 
1 2 3 4 5 
Tangible Support 
5. Is there someone who would help take care 
of you if you had to stay in bed for several 
weeks? 
1 2 3 4 5 
6. Is there someone you could turn to if you 
needed to borrow $10, get a ride to the 
doctor, or some small immediate help? 
1 2 3 4 5 
7. Is there someone you could turn to if you 
needed to borrow several hundred dollars for 
a medical emergency? 
1 2 3 4 5 
8. Is there someone who could take care of 
your children if you got sick? 
1 2 3 4 5 
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